≡ Risteys
FG R12 + FR

Documentation Changelog GitHub Contact & Feedback

Schizoid personality disorder

DOID EFO Endpoint Browser PheWeb

F5_SCHIZPER

Endpoint definition

↥

Endpoint definition steps

FinnGen

Phenotype data

520210

1. Apply sex-specific rule

None

520210

2. Check conditions

None

520210

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

  • Hospital discharge: ICD-10 — F60.1
  • Hospital discharge: ICD-9 — 3012
  • Hospital discharge: ICD-8 — 3012
  • Cause of death: ICD-10 — F60.1
  • Cause of death: ICD-9 — 3012
  • Cause of death: ICD-8 — 3012

2 out of 7 registries used, show all original rules.

669

4. Check minimum number of events

None

669

5. Include endpoints

None

669

6. Filter based on genotype QC (FinnGen only)

669

Control definitions (FinnGen only)

Control exclude
F5_PERSOBEH

Extra metadata

Level in the ICD hierarchy
4
First used in FinnGen datafreeze
DF2
Parent code in ICD-10
F60
Name in latin
Personalitas schizoides

Case counts by codes

↥

FinnGen case counts by registry codes:

generic upset plot

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

All Female Male
Number of individuals
Whole population 6590 2151 4380
Only index persons 5602 1896 3706
Unadjusted period prevalence (%)
Whole population 0.10 0.06 0.12
Only index persons 0.12 0.07 0.14
Median age at first event (years)
Whole population 32.09 34.37 30.82
Only index persons 31.55 33.83 30.38

-FinnGen-

Key figures

All Female Male
Number of individuals 669 264 405
Unadjusted period prevalence (%) 0.14 0.09 0.18
Median age at first event (years) 31.86 33.56 30.75

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

No data

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

Matched cohort

Matched cases
639
Matched controls
6391
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
F60.1
ICD-10 Finland
Schizoid personality disorder
6731.4
323.0
349
*
112
Kela drug reimbursment
Severe psychotic and other severe mental disorders
56.0
323.0
426
220
N05AH03
ATC
olanzapine; systemic
30.1
201.6
282
163
N05AX08
ATC
risperidone; systemic
30.3
196.1
273
153
N05AA02
ATC
levomepromazine; systemic
36.9
170.0
221
90
3012C
ICD-9 Finland
Personality disorders, Schizoid personality disorder[PSYKOOSIPIIRTEINEN PERSOONALLISUUS]
+∞
164.9
151
*
N05AB03
ATC
perphenazine; systemic, rectal
39.9
151.1
192
68
N05AH04
ATC
quetiapine; oral
11.1
144.2
329
557
F20.9
ICD-10 Finland
Schizophrenia, unspecified
44.8
135.3
167
50
N05AF03
ATC
chlorprothixene; systemic
39.8
133.3
169
57
30120
ICD-8 Finland
Personality disorders, Schizoid
+∞
126.3
117
*
N05AX12
ATC
aripiprazole; systemic
22.5
113.6
170
101
F61.0
ICD-10 Finland
Mixed personality disorders
331.3
111.8
110
*
N03AG01
ATC
valproic acid; systemic, rectal
16.9
104.7
175
139
N06AB04
ATC
citalopram; systemic
7.4
103.5
311
729
N05AH02
ATC
clozapine; systemic
32.4
97.6
130
50
N05AC02
ATC
thioridazine; oral
41.2
96.4
121
36
F20.00
ICD-10 Finland
Paranoid schizophrenia continuous
33.5
94.8
125
46
F29
ICD-10 Finland
Unspecified nonorganic psychosis
17.7
91.4
149
108
N05CD07
ATC
temazepam; oral
10.2
90.6
197
267
N05BA01
ATC
diazepam; systemic, rectal
8.0
87.0
225
404
F60.31
ICD-10 Finland
Emotionally unstable personality disorder, borderline condition
+∞
86.4
81
*
T36
ICD-10 Finland
Poisoning by systemic antibiotics
18.0
85.7
138
96
F60.30
ICD-10 Finland
Emotionally unstable personality disorder, impulsive
936.6
85.7
82
*
F21
ICD-10 Finland
Schizotypal disorder
141.6
82.2
86
7
F32.2
ICD-10 Finland
Severe depressive episode without psychotic symptoms
11.3
78.0
157
179
P72
ICPC
Schizophrenia
29.7
77.3
105
42
X69
ICD-10 Finland
Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances
20.2
76.2
117
70
N05AA01
ATC
chlorpromazine; systemic, rectal
32.4
73.2
97
35
N05BA04
ATC
oxazepam; oral
5.3
73.2
285
839
N05AD01
ATC
haloperidol; systemic
20.7
73.1
111
64
N05BA06
ATC
lorazepam; systemic, sublingual
15.0
70.5
122
99
F60.9
ICD-10 Finland
Personality disorder, unspecified
+∞
69.0
65
*
F32.9
ICD-10 Finland
Depressive episode, unspecified
6.9
67.9
191
370
N04AA02
ATC
biperiden; systemic
23.8
66.4
96
47
F20.30
ICD-10 Finland
Undifferentiated schizophrenia continuous
28.1
65.5
90
37
N06AB03
ATC
fluoxetine; oral
6.5
62.1
183
372
2989X
ICD-9 Finland
Other nonorganic psychoses, Unspecified psychosis
47.1
61.7
75
18
N06AX16
ATC
venlafaxine; oral
5.7
60.6
202
478
N06AB06
ATC
sertraline; oral
6.6
60.4
174
342
N05AF05
ATC
zuclopenthixol; systemic
48.3
60.4
73
17
Z00.4
ICD-10 Finland
General psychiatric examination, not elsewhere classified
7.4
59.7
156
267
P99
ICPC
Psychological disorders other
17.5
59.1
95
63
F33.2
ICD-10 Finland
Recurrent depressive disorder, current episode severe without psychotic symptoms
12.1
58.4
111
109
F33.10
ICD-10 Finland
Recurrent depression, moderate episode without somatic syndrome
11.2
56.1
111
118
F25.9
ICD-10 Finland
Schizoaffective disorder, unspecified
35.1
55.6
72
23
188
Kela drug reimbursment
Psychosis requiring demanding treatment
31.0
54.0
72
26
3018D
ICD-9 Finland
Personality disorders, Other personality disorders[EPÄVAKAA PERSOONALLISUUS]
+∞
53.9
51
*
P29
ICPC
Psychological sympt/compl other
8.5
51.3
119
167
F32.10
ICD-10 Finland
Moderate depressive episode without somatic syndrome
7.1
51.2
136
234
N05AN01
ATC
lithium; oral
13.8
49.8
88
73
N05BE01
ATC
buspirone; oral
15.2
49.6
84
63
F10.1
ICD-10 Finland
Mental and behavioural disorders due to use of alcohol, Harmful use
7.1
48.6
129
221
3012A
ICD-9 Finland
Personality disorders, Schizoid personality disorder[ERISTÄYTYVÄ PERSOONALLISUUS]
+∞
48.6
46
*
SPAT1240
SPAT
Therapeutic discussion
5.9
48.4
151
320
F20.09
ICD-10 Finland
Paranoid schizophrenia UNS
40.4
47.2
59
16
N03AX09
ATC
lamotrigine; oral
9.4
47.0
102
127
F34.1
ICD-10 Finland
Dysthymia
12.9
45.1
82
72
N06AX11
ATC
mirtazapine; oral
3.5
44.4
288
1217
3018X
ICD-9 Finland
Personality disorders, Other personality disorders[MUU TAI SEKAMUOTOINEN PERSOONALLISUUSHÄIRIÖ]
126.6
44.4
47
*
F60.0
ICD-10 Finland
Paranoid personality disorder
+∞
44.3
42
*
N06AX03
ATC
mianserin; oral
10.1
43.0
89
101
F32.3
ICD-10 Finland
Severe depressive episode with psychotic symptoms
17.0
42.9
69
45
F41.9
ICD-10 Finland
Anxiety disorder, unspecified
6.2
42.8
125
241
F60.6
ICD-10 Finland
Anxious [avoidant] personality disorder
230.0
42.4
43
*
N03AE01
ATC
clonazepam; systemic
7.8
41.1
100
149
F60.3
ICD-10 Finland
Emotionally unstable personality disorder
422.9
40.6
40
*
F10.29
ICD-10 Finland
Addiction caused by alcohol UNS
12.5
39.3
72
64
N07BB01
ATC
disulfiram; oral
7.4
38.6
97
151
A06AD11
ATC
lactulose; oral
5.0
38.4
137
332
E950A
ICD-9 Finland
Suicide and self-inflicted poisoning by solid or liquid substances
35.2
38.1
49
15
F20.5
ICD-10 Finland
Residual schizophrenia
43.9
36.7
45
11
F33.30
ICD-10 Finland
Recurrent depression, severe episode without somatic syndrome
32.3
36.6
48
16
N05CF01
ATC
zopiclone; oral
3.2
36.3
263
1160
F33.9
ICD-10 Finland
Recurrent depressive disorder, unspecified
9.9
34.8
72
81
2968A
ICD-9 Finland
Affective psychoses, Manic-depressive psychosis, other and unspecified
36.2
34.5
44
13
N05AL01
ATC
sulpiride; systemic
19.4
34.2
52
29
30188
ICD-8 Finland
Personality disorders, Alia definita
+∞
33.6
32
*
N06AB05
ATC
paroxetine; oral
6.1
33.5
97
182
F20.0
ICD-10 Finland
Paranoid schizophrenia
31.4
33.4
44
15
N06AX12
ATC
bupropion; oral
6.0
33.3
98
188
ZY010
NOMESCO Finland
Hospital outpatient
8.2
33.3
77
105
F10.20
ICD-10 Finland
Alcohol dependence currently independent
12.1
33.0
61
55
F60.8
ICD-10 Finland
Other specific personality disorders
123.2
33.0
35
*
F10.21
ICD-10 Finland
Alcohol dependence currently abstinent, but staying in restrictive environment
25.4
32.3
45
19
ICZ03
NOMESCO Finland
Participation in compiling a psychiatric treatment plan
15.0
32.2
54
39
F41.2
ICD-10 Finland
Mixed anxiety and depressive disorder
5.0
32.2
112
261
N06AB10
ATC
escitalopram; oral
3.3
31.9
198
768
IGY02
NOMESCO Finland
Psychiatric monitoring contact
16.2
31.4
51
34
F31.9
ICD-10 Finland
Bipolar affective disorder, unspecified
9.7
31.2
65
74
F20
ICD-10 Finland
Schizophrenia
32.7
30.7
40
13
Z76.8
ICD-10 Finland
Persons encountering health services in other specified circumstances
9.2
30.3
65
78
N05BA02
ATC
chlordiazepoxide; systemic
11.1
30.1
58
57
3039X
ICD-9 Finland
Alcohol dependence syndrome, Other and unspecified alcohol dependence
22.9
30.0
43
20
2959A
ICD-9 Finland
Schizophrenic psychoses, Unspecified schizophrenia[ERILAISTUMATON SKITSOFRENIA,TARKEMMIN MÄÄRITTELEMÄT]
59.7
29.4
34
6
F99
ICD-10 Finland
Mental disorder, not otherwise specified
11.5
29.1
55
52
2959C
ICD-9 Finland
Schizophrenic psychoses, Unspecified schizophrenia[ERILAISTUMATON SKITSOFRENIA,KROONINEN]
46.1
29.0
35
8
SPAT1234
SPAT
Support of social functional capacity
8.6
28.4
63
80
F40.1
ICD-10 Finland
Social phobias
11.7
28.3
53
49
SPAT1222
SPAT
Counselling/guidance promoting independent living
4.2
28.2
118
328
F22.0
ICD-10 Finland
Delusional disorder
20.3
28.2
42
22
F25.10
ICD-10 Finland
Schizoaffective syndrome, depressive type with only concomitant bipolar and schizophrenic symptoms
30.1
27.9
37
13
IGY01
NOMESCO Finland
Accelerated psychiatric treatment contact
17.0
27.1
43
27
F61
ICD-10 Finland
Mixed and other personality disorders
282.3
26.9
27
*
N05AD03
ATC
melperone; systemic
20.2
26.9
40
21
X44
ICD-10 Finland
Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances
16.6
26.3
42
27
C07AA05
ATC
propranolol; systemic
3.1
26.2
170
667
IEY05
NOMESCO Finland
Dedicated profession-specific psychiatric intervention, individual
12.6
26.1
47
40
9691A
ICD-9 Finland
Poisoning by psychotropic agents, Phenothiazine-based tranquillisers
97.5
25.9
28
*
F20.04
ICD-10 Finland
Paranoid schizophrenia with partial recurrence
34.7
25.8
33
10
N06AA12
ATC
doxepin; systemic
7.0
25.7
65
101
F20.3
ICD-10 Finland
Undifferentiated schizophrenia
23.8
25.5
36
16
F25.20
ICD-10 Finland
Schizoaffective syndrome, mixed type with only concomitant bipolar and schizophrenic symptoms
37.3
25.4
32
9
P01
ICPC
Feeling anxious/nervous/tense
4.2
25.0
103
281
30041
ICD-8 Finland
Neuroses, Depressiva
23.1
24.6
35
16
F31.0
ICD-10 Finland
Bipolar affective disorder, current episode hypomanic
14.0
24.5
42
32
9694A
ICD-9 Finland
Poisoning by psychotropic agents, Benzodiazepine-based tranquillisers
50.5
24.5
29
6
N06AG02
ATC
moclobemide; oral
6.7
24.3
64
105
N05AX13
ATC
paliperidone; systemic
58.4
24.2
28
5
SPAT1254
SPAT
Administration of medicine
3.6
23.9
120
388
P80
ICPC
Personality disorder
90.2
23.8
26
*
ICB01
NOMESCO Finland
Psychiatric treatment plan, standard
12.4
23.8
43
37
9690A
ICD-9 Finland
Poisoning by psychotropic agents, Antidepressants
248.9
23.8
24
*
F20.39
ICD-10 Finland
Undifferentiated schizophrenia UNS
17.0
23.5
37
23
SPAT1243
SPAT
Psychiatric/psychological examination
10.1
23.4
47
50
F31.4
ICD-10 Finland
Bipolar affective disorder, current episode severe depression without psychotic symptoms
14.8
23.4
39
28
N06CA01
ATC
amitriptyline and psycholeptics; systemic
4.0
23.3
101
288
P28
ICPC
Limited function/disability (P)
19.9
22.8
34
18
N06AA04
ATC
clomipramine; systemic
12.8
22.6
40
33
F31.8
ICD-10 Finland
Other bipolar affective disorders
12.9
22.1
39
32
F31.30
ICD-10 Finland
Bipolar disorder Depressive episode without somatic syndrome
12.1
22.0
40
35
F60.2
ICD-10 Finland
Dissocial personality disorder
+∞
22.0
21
*
N05AF01
ATC
flupentixol; systemic
10.9
21.9
42
41
EBA00
NOMESCO Finland
Extraction of tooth
2.4
21.9
253
1372
29999
ICD-8 Finland
Unspecified psychosis
40.2
21.9
27
7
SPAT1250
SPAT
Comprehensive monitoring of chronic illness
2.7
21.8
180
810
N05BA12
ATC
alprazolam; oral
3.6
21.8
105
327
F60.5
ICD-10 Finland
Anankastic personality disorder
227.4
21.7
22
*
R56.8
ICD-10 Finland
Other and unspecified convulsions
5.3
21.6
68
140
F31.6
ICD-10 Finland
Bipolar affective disorder, current episode mixed
14.6
21.6
36
26
F25.00
ICD-10 Finland
Schizoaffective syndrome, manic type with only simultaneous bipolar and schizophrenic symptoms
19.7
21.5
32
17
F10.00
ICD-10 Finland
Alcohol-related acute intoxication uncomplicated
9.4
21.2
44
50
30180
ICD-8 Finland
Personality disorders, Immatura
79.5
20.8
23
*
A28
ICPC
Limited function/disability NOS
3.9
20.8
92
266
P76
ICPC
Depressive disorder
4.6
20.7
74
175
F33.4
ICD-10 Finland
Recurrent depressive disorder, currently in remission
10.6
20.6
40
40
WYA30
NOMESCO Finland
Preparations for expected poor cooperation
4.1
20.6
84
226
F10.26
ICD-10 Finland
Alcohol dependence periodic alcoholism
9.7
20.1
41
45
F10.25
ICD-10 Finland
Alcohol dependence continuous use
9.4
19.9
41
46
2961C
ICD-9 Finland
Affective psychoses, Manic disorder, recurrent episode[VAKAVA MASENNUSTILA,KESKIVAIKEA]
75.9
19.8
22
*
2954A
ICD-9 Finland
Schizophrenic psychoses, Acute schizophrenic episode
30.0
19.8
26
9
SPAT1307
SPAT
Psychosocial counselling and guidance
4.7
19.6
69
160
F41.1
ICD-10 Finland
Generalized anxiety disorder
5.5
19.6
59
115
F20.8
ICD-10 Finland
Other schizophrenia
32.4
19.4
25
8
P15
ICPC
Chronic alcohol abuse
6.0
19.3
54
96
F32.00
ICD-10 Finland
Mild depressive episode without somatic syndrome
6.2
19.3
53
92
2961E
ICD-9 Finland
Affective psychoses, Manic disorder, recurrent episode[VAKAVA MASENNUSTILA,VAIKEA-ASTEINEN+PSYKOOT PIIRTEI]
47.6
19.3
23
5
30000
ICD-8 Finland
Neuroses, Anxiety neurosis
27.0
19.3
26
10
N06AA09
ATC
amitriptyline; systemic
3.7
19.0
89
270
N03AF01
ATC
carbamazepine; oral, rectal
5.0
18.9
63
138
F10.24
ICD-10 Finland
Alcohol depence active use
10.3
18.9
37
38
P74
ICPC
Anxiety disorder/anxiety state
6.7
18.6
48
77
Z2446
NOMESCO Finland
Social worker
4.5
18.4
68
166
29599
ICD-8 Finland
Schizophrenia, Unspecified type
25.9
18.3
25
10
F25.11
ICD-10 Finland
Schizoaffective syndrome, depressive type with prolonged schizophrenic than bipolar symptoms
45.4
18.3
22
5
ZXE02
NOMESCO Finland
Procedure duration 10 to 19 minutes
5.5
18.2
55
108
N06AB08
ATC
fluvoxamine; oral
7.5
18.1
43
61
ZXE13
NOMESCO Finland
Procedure duration 90 to 119 minutes
6.7
18.0
46
73
29580
ICD-8 Finland
Schizophrenia, Other
27.6
17.9
24
9
IGY99
NOMESCO Finland
Other psychiatric treatment contact
11.5
17.9
33
30
T90
ICPC
Diabetes non-insulin dependent
2.5
17.9
158
730
K08.3
ICD-10 Finland
Retained dental root
4.0
17.8
74
202
N05AB01
ATC
dixyrazine; systemic
13.0
17.8
31
25
F33.00
ICD-10 Finland
Recurrent depression, mild episode without somatic syndrome
7.6
17.5
41
57
30088
ICD-8 Finland
Neuroses, Other
29.7
17.5
23
8
SPAT1301
SPAT
No procedures
2.3
17.2
209
1132
ZXE11
NOMESCO Finland
Procedure duration 60 to 89 minutes
4.6
17.1
61
144
F19.1
ICD-10 Finland
Mental and behavioural disorders due to multiple drug use and use of other psychoactive substances, harmful use
26.4
17.0
23
9
SPAT1253
SPAT
Initiation, adjustment, discontinuation or repetition of medication
2.3
16.8
202
1086
F20.10
ICD-10 Finland
Raise schizophrenia continuously
36.1
16.8
21
6
F39
ICD-10 Finland
Unspecified mood [affective] disorder
9.0
16.6
35
41
F32.11
ICD-10 Finland
Moderate depressive episode with somatic syndrome
7.3
16.4
39
56
F19.20
ICD-10 Finland
Addiction relationship caused by several drugs in combination and by other psychoactive substances currently independent
48.8
16.1
19
*
2959E
ICD-9 Finland
Schizophrenic psychoses, Unspecified schizophrenia[ERILAISTUMATON SKITSOFRENIA,KROONINEN AKUUTTI VAIHE]
48.8
16.1
19
*
3000A
ICD-9 Finland
Neurotic disorders, Anxiety states[TARKEMMIN MÄÄRITTELEMÄTÖN AHDISTUNEISUUSHÄIRIÖ]
25.2
16.1
22
9
SPAT1309
SPAT
Guidance related to psychoactive substances / risk behaviour
6.2
16.0
43
73
L17
ICPC
Foot/toe symptom/complaint
2.4
16.0
156
755
N06AA06
ATC
trimipramine; systemic
7.6
16.0
37
51
E9509
ICD-8 Finland
Suicide and self-inflicted poisoning by solid or liquid substances, Other and unspecified solid and liquid substances
61.6
15.8
18
*
AA400
NOMESCO Finland
Electroconvulsive therapy
16.2
15.8
25
16
SPAT1306
SPAT
Counselling and guidance related to nutrition and weight management
3.0
15.8
101
381
N05BA05
ATC
potassium clorazepate; oral
17.8
15.7
24
14
N05CD02
ATC
nitrazepam; oral
14.2
15.6
26
19
2971A
ICD-9 Finland
Paranoid states, Paranoia
163.8
15.5
16
*
N06AX21
ATC
duloxetine; oral
3.1
15.5
92
332
P98
ICPC
Psychosis NOS/other
15.2
15.5
25
17
2953E
ICD-9 Finland
Schizophrenic psychoses, Paranoid type[PARANOIDISTYYPPINEN SKITSOFRENIA,KROONINEN AKUUTTI]
39.1
15.5
19
5
30040
ICD-8 Finland
Neuroses, Neurotico-depressiva
29.4
15.3
20
7
M03BX02
ATC
tizanidine; oral
0.5
15.1
215
3211
A04
ICPC
Weakness/tiredness general
3.2
15.0
83
284
SPAT1251
SPAT
Organisation of medication
6.7
15.0
38
60
ZXE06
NOMESCO Finland
Procedure duration 50 to 59 minutes
4.7
15.0
51
115
30300
ICD-8 Finland
Alcoholism, Episodic excessive drinking
21.7
14.7
21
10
F60.7
ICD-10 Finland
Dependent personality disorder
+∞
14.6
14
*
ZY000
NOMESCO Finland
Hospital inpatient
14.6
14.6
24
17
2957A
ICD-9 Finland
Schizophrenic psychoses, Schizo-affective type
82.0
14.6
16
*
N05AE04
ATC
ziprasidone; systemic
15.8
14.5
23
15
EBA15
NOMESCO Finland
Extraction of large number of teeth
5.3
14.4
44
88
N06AX18
ATC
reboxetine; oral
13.8
14.3
24
18
F25.21
ICD-10 Finland
Schizoaffective syndrome, mixed type with prolonged schizophrenic than bipolar symptoms
22.9
14.3
20
9
F25.2
ICD-10 Finland
Schizoaffective disorder, mixed type
43.5
14.2
17
*
E970A
ICD-9 Finland
Injury due to legal intervention by firearms
43.5
14.2
17
*
IBZ01
NOMESCO Finland
Profession-specific psychiatric evaluation
10.4
14.1
27
27
ICB03
NOMESCO Finland
Psychiatric treatment plan, monitoring
16.2
14.0
22
14
G04BD04
ATC
oxybutynin; oral, transdermal
5.1
14.0
44
91
F10.9
ICD-10 Finland
Mental and behavioural disorders due to use of alcohol, Unspecified mental and behavioural disorder
18.0
13.9
21
12
F25.01
ICD-10 Finland
Schizoaffective syndrome, manic type with prolonged schizophrenic than bipolar symptoms
20.6
13.8
20
10
F31.1
ICD-10 Finland
Bipolar affective disorder, current episode manic without psychotic symptoms
10.8
13.8
26
25
3050A
ICD-9 Finland
Nondependent abuse of drugs, Alcohol abuse
14.0
13.8
23
17
OAB43
SPAT
NA
0.3
13.6
22
795
F20.6
ICD-10 Finland
Simple schizophrenia
76.8
13.6
15
*
IAA01
NOMESCO Finland
Assessment of need for psychiatric treatment
6.4
13.5
35
57
P27
ICPC
Fear of mental disorder
13.2
13.5
23
18
N06AX26
ATC
vortioxetine; oral
3.8
13.4
58
164
F10.23
ICD-10 Finland
Alcohol dependence currently abstinent but using aversion-inducing or inhibitory medication
26.4
13.4
18
7
G40.9
ICD-10 Finland
Epilepsy, unspecified
5.4
13.4
40
78
IER04
NOMESCO Finland
Rehabilitative psychiatric group intervention, functional
21.7
13.4
19
9
M01AH05
ATC
etoricoxib; oral
0.5
13.4
197
2952
F25.1
ICD-10 Finland
Schizoaffective disorder, depressive type
41.0
13.2
16
*
X61
ICD-10 Finland
Intentional self-poisoning by and exposure to antiepileptic, sedative-hypnotic, antiparkinsonism and psychotropic drugs, not elsewhere classified
41.0
13.2
16
*
103
Kela drug reimbursment
Diabetes, insulin-treated
2.1
13.2
166
897
A10BA02
ATC
metformin; oral
2.1
13.1
169
921
ZXY51
NOMESCO Finland
2-person team, doctor-nurse
11.3
13.1
24
22
Z08
ICPC
Social welfare problem
11.3
13.1
24
22
SPAT1156
SPAT
Guidance concerning treatment of rash and skin
2.9
13.1
86
328
V03AA01
ATC
NA
9.0
13.1
27
31
29530
ICD-8 Finland
Schizophrenia, Paranoid type
23.1
12.9
18
8
N06AX05
ATC
trazodone; oral
6.8
12.9
32
49
IFA99
NOMESCO Finland
Other psychiatric pharmacotherapy service
51.1
12.9
15
*
F10.09
ICD-10 Finland
Alcohol intoxication UNS
6.2
12.9
34
57
J18.9
ICD-10 Finland
Pneumonia, unspecified
2.2
12.8
140
709
P03
ICPC
Feeling depressed
3.1
12.7
73
258
P73
ICPC
Affective psychosis
17.8
12.6
19
11
F19.21
ICD-10 Finland
Addiction caused by several drugs in combination and by other psychoactive substances currently independent but staying in a controlling environment
+∞
12.5
12
*
F20.03
ICD-10 Finland
Paranoid schizophrenia periodically with gradual improvement
+∞
12.5
12
*
F20.02
ICD-10 Finland
Paranoid schizophrenia stable periodically
24.9
12.5
17
7
F42.2
ICD-10 Finland
Mixed obsessional thoughts and acts
20.5
12.5
18
9
E11.9
ICD-10 Finland
Type 2 diabetes mellitus, without complications
2.2
12.5
136
686
215
Kela drug reimbursment
Diabetes, non-insulin-treated
2.1
12.4
157
850
N05AC01
ATC
periciazine; systemic
38.3
12.2
15
*
F31.7
ICD-10 Finland
Bipolar affective disorder, currently in remission
6.5
12.1
31
50
F33.11
ICD-10 Finland
Recurrent depression, moderate episode of somatic syndrome
7.5
12.1
28
39
2988A
ICD-9 Finland
Other nonorganic psychoses, Other and unspecified reactive psychosis
27.3
12.1
16
6
Z03
ICPC
Housing/neighbourhood problem
27.3
12.1
16
6
R53
ICD-10 Finland
Malaise and fatigue
2.3
12.1
123
600
2951C
ICD-9 Finland
Schizophrenic psychoses, Disorganised type[HEBEFREENISTYYPPINEN SKITSOFRENIA,KROONINEN]
47.6
11.9
14
*
F10.30
ICD-10 Finland
Withdrawal symptoms caused by alcohol uncomplicated
9.2
11.8
24
27
F31.20
ICD-10 Finland
Bipolar disorder, manic episode with mood-congruent psychotic symptoms
9.2
11.8
24
27
WZB00
NOMESCO Finland
Telephone receipt or other advice
2.0
11.7
194
1163
IFA01
NOMESCO Finland
Psychiatric pharmacotherapy plan, not specified
12.9
11.7
20
16
J01FA10
ATC
azithromycin; systemic
0.5
11.7
197
2884
N05AB02
ATC
fluphenazine; systemic
23.4
11.6
16
7
30310
ICD-8 Finland
Alcoholism, Habitual excessive drinking
23.4
11.6
16
7
A46
ICD-10 Finland
Erysipelas
2.5
11.5
94
410
IGV01
NOMESCO Finland
Psychiatric network contact
13.9
11.5
19
14
30199
ICD-8 Finland
Personality disorders, Unspecified
+∞
11.5
11
*
F61.1
ICD-10 Finland
Disturbing personality change
+∞
11.5
11
*
B18.2
ICD-10 Finland
Chronic viral hepatitis C
8.6
11.4
24
29
SPAT1244
SPAT
Occupational therapy
15.4
11.4
18
12
29510
ICD-8 Finland
Schizophrenia, Hebephrenic type
35.7
11.3
14
*
Z72.8
ICD-10 Finland
Other problems related to lifestyle
17.4
11.2
17
10
ZYB04
NOMESCO Finland
Outreach service in patient’s home or everyday environment
25.5
11.2
15
6
S22
ICPC
Nail symptom/complaint
3.7
11.2
48
136
ZXE05
NOMESCO Finland
Procedure duration 40 to 49 minutes
3.7
11.2
48
136
SPAT1263
SPAT
Sampling
1.8
11.0
258
1740
ZXE03
NOMESCO Finland
Procedure duration 20 to 29 minutes
3.6
10.9
50
149
F84.5
ICD-10 Finland
Asperger syndrome
18.2
10.8
16
9
ZXE15
NOMESCO Finland
Procedure duration 120 to 149 minutes
7.7
10.7
24
32
K59.0
ICD-10 Finland
Constipation
4.1
10.6
41
106
SPAT1252
SPAT
Overall medication plan or its review
3.5
10.5
48
143
AA1AD
NOMESCO Finland
CT of head and brain
2.1
10.5
131
697
F43.1
ICD-10 Finland
Post-traumatic stress disorder
7.0
10.5
25
37
F19.00
ICD-10 Finland
Intoxication caused by several drugs in combination or by other psychoactive substances uncomplicated
+∞
10.4
10
*
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
2.6
10.4
81
343
ICB02
NOMESCO Finland
Psychiatric treatment plan, extended/prolonged
12.3
10.4
18
15
SPAT1249
SPAT
Treatment-related counselling outside office
1.8
10.4
236
1566
F10.2
ICD-10 Finland
Mental and behavioural disorders due to use of alcohol, Dependence syndrome
10.8
10.3
19
18
ZXY49
NOMESCO Finland
Other health care provider
19.2
10.3
15
8
A01
ICPC
Pain general/multiple sites
3.3
10.2
51
163
P18
ICPC
Medication abuse
13.4
10.2
17
13
SPAT1310
SPAT
Counselling related to known health issue
1.9
10.2
194
1210
F31.5
ICD-10 Finland
Bipolar affective disorder, current episode severe depression with psychotic symptoms
14.9
10.0
16
11
29500
ICD-8 Finland
Schizophrenia, Simple type
40.7
10.0
12
*
F20.08
ICD-10 Finland
Paranoid schizophrenia other definite
40.7
10.0
12
*
97010
ICD-8 Finland
Adverse effect of psychotherapeutics, Tranquillisers
40.7
10.0
12
*
SPAT1260
SPAT
Consultation of another employee
2.2
10.0
105
517
F25
ICD-10 Finland
Schizoaffective disorders
17.0
9.9
15
9
K59.09
ICD-10 Finland
Constipation, unspecified
3.5
9.9
45
134
U04
ICPC
Incontinence urine
5.0
9.9
31
65
N03AX11
ATC
topiramate; oral
5.0
9.9
31
65
R11
ICD-10 Finland
Nausea and vomiting
3.0
9.8
56
196
F23.90
ICD-10 Finland
Acute and transient psychosis, unspecified without acute stress factor
20.4
9.8
14
7
ZYC01
NOMESCO Finland
Remote contact by phone
3.9
9.8
39
104
J44.8
ICD-10 Finland
Other specified chronic obstructive pulmonary disease
2.9
9.8
58
210
SPAT1241
SPAT
Extensive assessment of psychosocial situation
8.0
9.7
21
27
K04.7
ICD-10 Finland
Periapical abscess without sinus
3.1
9.7
52
176
29540
ICD-8 Finland
Acute schizophrenia episode
55.8
9.7
11
*
F44.9
ICD-10 Finland
Dissociative [conversion] disorder, unspecified
55.8
9.7
11
*
H03AA01
ATC
levothyroxine sodium; systemic
2.0
9.6
125
678
F19.29
ICD-10 Finland
Addiction caused by several drugs in combination and by other psychoactive substances UNS
15.3
9.5
15
10
3092D
ICD-9 Finland
Adjustment reaction, With predominant disturbance of other emotions[AHDISTUNEISUUTENA ILMENEVÄ SOPEUTUMISHÄIRIÖ]
17.9
9.4
14
8
F13.20
ICD-10 Finland
Addiction relationship caused by sedatives and hypnotics currently independent
17.9
9.4
14
8
2961D
ICD-9 Finland
Affective psychoses, Manic disorder, recurrent episode[VAKAVA MASENNUSTILA,VAIKEA-ASTEINEN]
17.9
9.4
14
8
X78
ICD-10 Finland
Intentional self-harm by sharp object
17.9
9.4
14
8
30320
ICD-8 Finland
Alcoholism, Alcoholic addiction
17.9
9.4
14
8
F13.29
ICD-10 Finland
Addiction caused by sedative and hypnotic UNS
30.5
9.4
12
*
Z29
ICPC
Social problem NOS
8.2
9.4
20
25
2959D
ICD-9 Finland
Schizophrenic psychoses, Unspecified schizophrenia[ERILAISTUMATON SKITSOFRENIA,SUBKROONINEN AKUUTTI]
+∞
9.4
9
*
F20.01
ICD-10 Finland
Paranoid schizophrenia periodically with gradual deterioration
22.1
9.4
13
6
T50.9
ICD-10 Finland
Poisoning: Other and unspecified drugs, medicaments and biological substances
22.1
9.4
13
6
Z72.2
ICD-10 Finland
Drug use
22.1
9.4
13
6
N05AE03
ATC
sertindole; oral
22.1
9.4
13
6
SPAT1312
SPAT
General health counselling
1.8
9.3
196
1261
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
1.8
9.3
207
1356
F10.39
ICD-10 Finland
Withdrawal symptoms caused by alcohol UNS
7.4
9.3
21
29
F31.31
ICD-10 Finland
Bipolar disorder depressive episode with somatic syndrome
13.9
9.2
15
11
N02AE01
ATC
buprenorphine; parenteral, sublingual, transdermal
2.6
9.2
65
262
OAA65
SPAT
NA
0.2
9.1
8
412
SPAT1217
SPAT
Assessment of need for services (elderly/care support)
4.2
9.1
33
81
IGY02
SPAT
NA
10.2
9.1
17
17
F20.32
ICD-10 Finland
Undifferentiated schizophrenia stable periodically
37.2
9.0
11
*
29830
ICD-8 Finland
Other psychoses, Acute paranoid reaction
37.2
9.0
11
*
F92.0
ICD-10 Finland
Depressive conduct disorder
37.2
9.0
11
*
P16
ICPC
Acute alcohol abuse
5.6
9.0
25
46
SPAT1148
SPAT
Treatment of chronic ulcer or burn
2.4
9.0
80
363
F42.1
ICD-10 Finland
Predominantly compulsive acts [obsessional rituals]
18.9
9.0
13
7
SPAT1033
SPAT
Irrigation or wax removal of outer auditory canal
2.1
8.8
106
553
R4160
NOMESCO Finland
Other therapy enhancing rehabilitation
6.1
8.8
23
39
K04.5
ICD-10 Finland
Chronic apical periodontitis
1.8
8.7
169
1054
F13.25
ICD-10 Finland
Addiction caused by sedative and hypnotic continuous use
14.3
8.7
14
10
N10
ICD-10 Finland
Acute tubulo-interstitial nephritis
2.5
8.7
68
289
SPAT1262
SPAT
Handing over of treatment supplies
2.0
8.7
111
595
F19.24
ICD-10 Finland
Addiction relationship caused by several drugs in combination and by other psychoactive substances active addiction
50.7
8.7
10
*
F32.1
ICD-10 Finland
Moderate depressive episode
3.1
8.6
47
161
SPAT1137
SPAT
Taking care of patient’s/customer’s hygiene
4.9
8.6
27
57
SPAT1216
SPAT
Assessment of functional ability
2.4
8.6
71
311
G72.8
ICD-10 Finland
Other specified myopathies
8.4
8.6
18
22
F41.00
ICD-10 Finland
Moderate panic disorder
7.1
8.6
20
29
N06AX22
ATC
agomelatine; oral
5.3
8.5
25
49
R41.0
ICD-10 Finland
Disorientation, unspecified
6.5
8.5
21
33
F15.2
ICD-10 Finland
Mental and behavioural disorders due to use of other stimulants, including caffeine, dependence syndrome
27.9
8.5
11
*
IEV99
NOMESCO Finland
Other psychiatric network intervention
27.9
8.5
11
*
29570
ICD-8 Finland
Schizophrenia, Schizo-affective type
27.9
8.5
11
*
3004A
ICD-9 Finland
Neurotic disorders, Neurotic depression
27.9
8.5
11
*
A29
ICPC
General symptom/complaint other
2.6
8.5
64
267
F05.9
ICD-10 Finland
Delirium, unspecified
7.5
8.5
19
26
F51.0
ICD-10 Finland
Nonorganic insomnia
2.2
8.4
89
440
2956C
ICD-9 Finland
Schizophrenic psychoses, Residual schizophrenia[RESIDUAALINEN SKITSOFRENIA,KROONINEN]
91.2
8.4
9
*
F25.80
ICD-10 Finland
Other specified schizoaffective disorder with only concomitant bipolar and schizophrenic symptoms
91.2
8.4
9
*
3049X
ICD-9 Finland
Drug dependence, Unspecified drug dependence
91.2
8.4
9
*
SPE90
NOMESCO Finland
Other fitting and preparation of partial tooth prosthesis
6.3
8.4
21
34
ZXE01
NOMESCO Finland
Procedure duration 0 to 9 minutes
6.0
8.4
22
38
3041A
ICD-9 Finland
Drug dependence, Barbiturate and similarly acting sedative or hypnotic dependence
+∞
8.3
8
*
ZYB08
NOMESCO Finland
Outreach service elsewhere in the private sector or third sector
+∞
8.3
8
*
F20.34
ICD-10 Finland
Undifferentiated schizophrenia with partial recurrence
10.9
8.3
15
14
SPAT1220
SPAT
Assessment of need for rehabilitation and/or rehabilitation plan
3.0
8.3
47
164
F32.8
ICD-10 Finland
Other depressive episodes
7.7
8.2
18
24
SPAT1100
SPAT
Long-term monitoring of blood pressure
3.4
8.2
38
116
F41.8
ICD-10 Finland
Other specified anxiety disorders
4.3
8.2
29
70
S97
ICPC
Chronic ulcer skin
3.5
8.1
36
106
E000003
ATC
NA
3.6
8.1
35
101
F42.0
ICD-10 Finland
Predominantly obsessional thoughts or ruminations
17.4
8.1
12
7
ICB03
SPAT
NA
17.4
8.1
12
7
2961A
ICD-9 Finland
Affective psychoses, Manic disorder, recurrent episode[VAKAVA MASENNUSTILA,TARKEMMIN MÄÄRITTELEMÄTÖN]
33.8
8.1
10
*
F20.38
ICD-10 Finland
Undifferentiated schizophrenia other definite
33.8
8.1
10
*
F33.3
ICD-10 Finland
Recurrent depressive disorder, current episode severe with psychotic symptoms
33.8
8.1
10
*
Z28
ICPC
Limited function/disability (Z)
33.8
8.1
10
*
Z91.5
ICD-10 Finland
Personal history of self-harm
22.3
8.0
11
5
111
Kela drug reimbursment
Epilepsy and comparable convulsive disorders
3.0
7.9
43
148
U07.1
ICD-10 Finland
Emergency use of U07.1 | COVID-19, virus identified
0.4
7.9
32
762
SPAT1292
SPAT
Other function in accordance with SHToL (Finnish classification of nursing interventions)
2.6
7.8
56
225
F41.09
ICD-10 Finland
UNS Panic Syndrome
4.2
7.8
28
69
H13
ICPC
Plugged feeling ear
2.0
7.7
98
521
F19.2
ICD-10 Finland
Mental and behavioural disorders due to multiple drug use and use of other psychoactive substances, dependence syndrome
45.5
7.7
9
*
T65.9
ICD-10 Finland
Toxic effect: Toxic effect of unspecified substance
45.5
7.7
9
*
ZXY03
NOMESCO Finland
Occupational therapist
45.5
7.7
9
*
F10.40
ICD-10 Finland
Withdrawal symptoms and delirium caused by alcohol without seizures
7.6
7.7
17
23
U07
ICPC
Urine symptom/complaint other
3.4
7.7
35
106
N39.4
ICD-10 Finland
Other specified urinary incontinence
3.1
7.7
40
134
R95
ICPC
Chron obstructive pulmonary disease
5.0
7.6
23
47
E11
ICD-10 Finland
Type 2 diabetes mellitus
2.1
7.6
88
452
F34.9
ICD-10 Finland
Persistent mood [affective] disorder, unspecified
18.6
7.6
11
6
EBA30
NOMESCO Finland
Excision of root of tooth
2.9
7.6
44
157
F33.8
ICD-10 Finland
Other recurrent depressive disorders
12.0
7.6
13
11
3090A
ICD-9 Finland
Adjustment reaction, Brief depressive reaction
25.3
7.6
10
*
ICC04
NOMESCO Finland
Psychiatric treatment plan, permanent discontinuation
6.3
7.6
19
31
F22.9
ICD-10 Finland
Persistent delusional disorder, unspecified
25.3
7.6
10
*
C03CA01
ATC
furosemide; systemic
1.9
7.6
117
673
ZXE04
NOMESCO Finland
Procedure duration 30 to 39 minutes
3.0
7.6
43
151
J44.9
ICD-10 Finland
Chronic obstructive pulmonary disease, unspecified
4.1
7.6
28
71
K02.1
ICD-10 Finland
Caries of dentine
1.6
7.5
366
2920
Z02.7
ICD-10 Finland
Issue of medical certificate
2.8
7.4
47
177
30099
ICD-8 Finland
Neuroses, Unspecified neurosis
81.0
7.4
8
*
F23.20
ICD-10 Finland
Acute schizophrenia-like psychosis without acute stress factor
81.0
7.4
8
*
F10.52
ICD-10 Finland
Psychotic alcohol hallucination
81.0
7.4
8
*
9693X
ICD-9 Finland
Poisoning by psychotropic agents, Other antipsychotics, neuroleptics and major tranquillisers
81.0
7.4
8
*
IER02
NOMESCO Finland
Dedicated profession-specific psychiatric intervention, group
13.6
7.4
12
9
NGD05
NOMESCO Finland
Partial excision of meniscus of knee, arthroscopic
0.3
7.4
14
469
Z76.9
ICD-10 Finland
Person encountering health services in unspecified circumstances
2.6
7.3
53
215
F19.26
ICD-10 Finland
Addiction relationship caused by several drugs in combination and by other psychoactive substances periodic addiction
+∞
7.3
7
*
F15.3
ICD-10 Finland
Mental and behavioural disorders due to use of other stimulants, including caffeine, withdrawal state
+∞
7.3
7
*
-1
NOMESCO Finland
NA
1.7
7.3
205
1417
-
ICD-10 Finland
NA
4.5
7.2
24
55
OAA67
SPAT
NA
0.2
7.2
6
324
S76
ICPC
Skin infection other
3.1
7.2
37
123
F23.29
ICD-10 Finland
Acute schizophrenia-like psychosis UNS
30.4
7.2
9
*
N05AA03
ATC
promazine; systemic
30.4
7.2
9
*
IBZ02
NOMESCO Finland
Somatic assessment of psychiatric patient
30.4
7.2
9
*
7890A
ICD-9 Finland
Other symptoms involving abdomen and pelvis, Abdominal pain
3.0
7.2
39
135
F70.0
ICD-10 Finland
Mild mental retardation, With the statement of no, or minimal, impairment of behaviour
20.3
7.1
10
5
F13.22
ICD-10 Finland
Addiction relationship caused by sedatives and hypnotics currently independent but uses substitute intermittent medication
20.3
7.1
10
5
F25.0
ICD-10 Finland
Schizoaffective disorder, manic type
20.3
7.1
10
5
SPAT1284
SPAT
Extensive health certificate
3.9
7.1
28
75
IBA01
NOMESCO Finland
Diagnostic and symptom-mapping evaluation
8.1
7.1
15
19
M01AB05
ATC
diclofenac; systemic, rectal
0.6
7.1
274
3454
P06
ICPC
Sleep disturbance
2.3
7.1
64
294
SPAT1221
SPAT
Guidance concerning rehabilitation services and livelihood
6.1
7.1
18
30
J15.9
ICD-10 Finland
Bacterial pneumonia, unspecified
2.6
7.1
52
213
R41.8
ICD-10 Finland
Other and unspecified symptoms and signs involving cognitive functions and awareness
2.7
7.1
47
184
F31.3
ICD-10 Finland
Bipolar affective disorder, current episode mild or moderate depression
7.1
7.0
16
23
Z03.2
ICD-10 Finland
Observation for suspected mental and behavioural disorders
5.0
7.0
21
43
Z2445
NOMESCO Finland
Psychologist
3.3
7.0
33
103
S06.0
ICD-10 Finland
Concussion
2.3
7.0
65
301
R03BB04
ATC
tiotropium bromide; inhalant
2.4
7.0
58
257
K08.1
ICD-10 Finland
Loss of teeth due to accident, extraction or local periodontal disease
2.4
7.0
58
257
Z72.1
ICD-10 Finland
Alcohol use
5.6
7.0
19
35
SPAT1256
SPAT
Intramuscular and subcutaneous injection
1.6
7.0
230
1657
E11.8
ICD-10 Finland
Type 2 diabetes mellitus, with unspecified complications
2.5
7.0
54
228
S01.0
ICD-10 Finland
Open wound of scalp
2.6
6.9
48
193
OAB48
SPAT
NA
0.2
6.8
9
366
SPAT1104
SPAT
Monitoring of emergency patient
2.8
6.8
43
161
F50.9
ICD-10 Finland
Eating disorder, unspecified
9.4
6.8
13
14
X80
ICD-10 Finland
Intentional self-harm by jumping from a high place
40.5
6.8
8
*
F42.9
ICD-10 Finland
Obsessive-compulsive disorder, unspecified
40.5
6.8
8
*
N05AE05
ATC
lurasidone; oral
40.5
6.8
8
*
3000B
ICD-9 Finland
Neurotic disorders, Anxiety states[PANIIKKIHÄIRIÖ]
40.5
6.8
8
*
F20.19
ICD-10 Finland
Hebefren schizophrenia UNS
40.5
6.8
8
*
P50
ICPC
Psychological, Medication/prescr/renewal
16.9
6.8
10
6
ZXY60
NOMESCO Finland
2-person team, nurses
16.9
6.8
10
6
F40.01
ICD-10 Finland
Agoraphobia with concomitant panic disorder
16.9
6.8
10
6
2953C
ICD-9 Finland
Schizophrenic psychoses, Paranoid type[PARANOIDISTYYPPINEN SKITSOFRENIA,KROONINEN]
16.9
6.8
10
6
I95.1
ICD-10 Finland
Orthostatic hypotension
5.0
6.7
20
41
3000C
ICD-9 Finland
Neurotic disorders, Anxiety states[YLEISTYNYT TUSKAISUUS]
22.8
6.7
9
*
F20.1
ICD-10 Finland
Hebephrenic schizophrenia
22.8
6.7
9
*
IEV99
SPAT
NA
22.8
6.7
9
*
F31
ICD-10 Finland
Bipolar affective disorder
5.3
6.7
19
37
R51.80
ICD-10 Finland
Headache
2.0
6.6
88
475
J01FA09
ATC
clarithromycin; systemic
0.6
6.6
85
1386
WYA05
NOMESCO Finland
Emergency visit or other similar visit involving procedures
1.5
6.6
299
2316
U07.2
ICD-10 Finland
COVID-19, virus not identified
0.4
6.6
35
754
ZXE21
NOMESCO Finland
Procedure duration at least 3 but less than 4 hours
12.4
6.6
11
9
J01AA02
ATC
doxycycline; systemic
0.6
6.6
334
4012
SPAT1225
SPAT
Implementation of podiatry rehabilitation plan
4.2
6.6
23
56
Z53.2
ICD-10 Finland
Procedure not carried out because of patient's decision for other and unspecified reasons
7.0
6.5
15
22
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
2.0
6.5
82
437
E11.00
ICD-10 Finland
Non-insulin dependent diabetes diabetic hypoglycaemic coma
4.6
6.5
21
47
S10
ICPC
Boil/carbuncle
2.9
6.5
38
138
N03AF02
ATC
oxcarbazepine; oral
3.6
6.5
27
77
SPAT1276
SPAT
Outlining of treatment with patient or their family members
4.8
6.5
20
43
IAB12
NOMESCO Finland
Psychiatric psychosis consultation
70.5
6.4
7
*
N05AE02
ATC
molindone; oral
70.5
6.4
7
*
F93.89
ICD-10 Finland
Other childhood emotional disorders
70.5
6.4
7
*
O80.0
ICD-10 Finland
Spontaneous vertex delivery
0.4
6.4
26
617
L28
ICPC
Limited function/disability (L)
2.2
6.4
66
323
R42
ICD-10 Finland
Dizziness and giddiness
1.9
6.4
104
607
IHZ05
SPAT
NA
4.7
6.3
20
44
Z00.0
ICD-10 Finland
General medical examination
1.8
6.3
107
634
XA400
NOMESCO Finland
EEG
18.2
6.3
9
5
F19.25
ICD-10 Finland
Addiction caused by several drugs in combination and by other psychoactive substances continuously used
18.2
6.3
9
5
IBB03
NOMESCO Finland
Assessment of vocational rehabilitation needs in a mental health context
18.2
6.3
9
5
SPAT1226
SPAT
Implementation of occupational therapy rehabilitation plan
4.9
6.3
19
40
2961B
ICD-9 Finland
Affective psychoses, Manic disorder, recurrent episode[VAKAVA MASENNUSTILA,LIEVÄASTEINEN]
+∞
6.3
6
*
29520
ICD-8 Finland
Schizophrenia, Catatonic type
+∞
6.3
6
*
G40.52
ICD-10 Finland
Epileptic seizures related to drugs
+∞
6.3
6
*
V628A
ICD-9 Finland
Other psychosocial circumstances, Other psychological or physical stress, not elsewhere classified
+∞
6.3
6
*
3016A
ICD-9 Finland
Personality disorders, Dependent personality disorder
+∞
6.3
6
*
K04.4
ICD-10 Finland
Acute apical periodontitis of pulpal origin
2.2
6.3
65
319
F63.0
ICD-10 Finland
Pathological gambling
26.9
6.2
8
*
F11.29
ICD-10 Finland
Addiction caused by opiates UNS
26.9
6.2
8
*
R44.0
ICD-10 Finland
Auditory hallucinations
26.9
6.2
8
*
F13.1
ICD-10 Finland
Mental and behavioural disorders due to use of sedatives or hypnotics, harmful use
26.9
6.2
8
*
E87.1
ICD-10 Finland
Hypo-osmolality and hyponatraemia
3.9
6.2
24
64
A13
ICPC
Concern/fear medical treatment
6.4
6.2
15
24
OAB42
SPAT
NA
3.0
6.2
35
123
F33.01
ICD-10 Finland
Recurrent depression, mild episode of somatic syndrome
12.7
6.1
10
8
-50
ICPC
Medication/prescr/renewal
3.5
6.1
26
76
G04BD07
ATC
tolterodine; oral
3.2
6.1
30
98
S29
ICPC
Skin symptom/complaint other
1.9
6.1
88
495
SPAT1229
SPAT
Assessment of need for aid
2.7
6.1
39
149
IHZ04
SPAT
NA
10.1
6.0
11
11
AA1BG
NOMESCO Finland
Standard MRI examination of brain with high intensity magnet
2.3
6.0
54
247
T74.1
ICD-10 Finland
Physical abuse
4.6
6.0
19
42
J20.9
ICD-10 Finland
Acute bronchitis, unspecified
1.8
6.0
98
574

LabWAS

↥
OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3009466) Valproate [Moles/volume] in Serum or Plasma
105
74
16.64
118.57
6.1
5.2
umol/l
373.0
347.9
0.64
95
66
(3028707) Methadone [Presence] in Urine by Screen method
66
93
7.76
45.26
1.9
3.7
—
—
—
0
0
(3019309) Folate [Moles/volume] in Red Blood Cells
166
688
2.88
28.02
1.9
1.7
nmol/l
1217.3
1166.2
0.30
135
533
(1001926) Buprenorphine [Presence] in Urine by Screen method
75
196
4.18
26.16
2.0
2.4
—
—
—
0
0
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
311
1831
2.31
24.31
4.4
3.6
u/l
34.0
33.2
0.12
292
1745
(3016879) Cocaine [Presence] in Urine
81
241
3.69
23.50
2.1
2.3
—
—
—
0
0
(3011288) Drugs identified in Urine by Screen method
65
169
4.15
22.77
2.8
3.4
—
—
—
0
0
(4198724)
25
25
10.35
22.16
1.7
1.3
—
—
—
0
0
(3019150) Specific gravity of Urine by Refractometry
212
1128
2.29
20.36
4.8
3.2
kg/l
1.0
1.0
0.13
29
147
(3000764) Benzodiazepines [Presence] in Urine
80
259
3.37
20.33
2.2
2.2
—
—
—
0
0
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
297
1811
2.15
20.28
2.1
1.8
pmol/l
96.5
96.8
0.03
156
966
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
524
4000
2.43
20.06
7.1
7.8
u/l
83.9
77.9
0.61
497
3791
(3028300) Cannabinoids [Presence] in Urine
80
263
3.32
19.83
2.2
2.1
—
—
—
0
0
(3013650) Neutrophils [#/volume] in Blood by Automated count
425
2991
2.15
19.71
24.6
9.5
e9/l
4.4
4.0
2.65
397
2642
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
174
863
2.37
19.58
3.0
2.0
%
1.6
1.5
1.53
160
775
(3015377) Calcium [Moles/volume] in Serum or Plasma
260
1533
2.14
19.11
2.7
3.6
mmol/l
2.3
2.4
1.27
223
1369
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
513
3920
2.32
18.93
5.1
3.5
pmol/l
14.4
14.7
1.24
484
3622
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
197
1046
2.25
18.79
2.4
2.0
mg/l
3.1
3.0
0.13
177
893
(3027944) Amphetamines [Presence] in Urine
78
261
3.25
18.76
2.1
2.0
—
—
—
0
0
(40758558) Short blood count panel - Blood
222
1240
2.18
18.66
14.8
7.0
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
78
263
3.23
18.53
2.2
2.2
—
—
—
0
0
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
177
931
2.23
17.07
1.9
1.6
pmol/l
35484320.2
20426491.0
0.16
155
798
(3021960) Folate [Moles/volume] in Serum or Plasma
185
999
2.18
16.66
1.7
1.5
nmol/l
18.6
20.9
1.15
159
867
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
339
2289
1.98
16.45
6.2
7.1
mmol/l
1.2
1.2
0.71
287
1978
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
313
2067
1.97
16.11
5.6
6.3
mmol/l
1.2
1.2
1.17
284
1902
(3013115) Eosinophils [#/volume] in Blood
382
2711
1.95
15.77
12.6
6.3
e9/l
0.2
0.2
2.29
347
2416
(3006315) Basophils [#/volume] in Blood
372
2617
1.95
15.76
10.4
6.0
e9/l
0.0
0.0
1.73
331
2301
(3001604) Monocytes [#/volume] in Blood
368
2607
1.91
14.97
10.6
6.0
e9/l
0.6
0.6
0.13
328
2293
(3009508) Creatinine [Moles/volume] in Urine
251
1579
1.94
14.53
2.9
3.2
mmol/l
6.9
8.6
5.99
207
1353
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
255
1616
1.93
14.42
3.0
2.8
u/l
50.5
57.8
3.06
231
1520
(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma
14
11
12.98
14.29
2.2
1.6
umol/l
13.3
18.1
0.71
14
11
(21494755) Public health laboratory ask at order entry panel
15
833
0.16
14.28
1.1
1.4
—
—
—
0
0
(3020191) Ethanol [Moles/volume] in Serum or Plasma
27
50
5.59
14.11
1.4
1.7
promille
1.4
1.1
0.26
20
42
(1761868) Lipid panel - Serum or Plasma
142
2423
0.47
13.92
3.5
2.6
—
—
—
0
0
(3024561) Albumin [Mass/volume] in Serum or Plasma
301
2034
1.87
13.82
3.9
5.3
g/l
35.3
36.5
2.70
276
1914
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
575
4824
2.37
13.79
6.2
4.1
mu/l
1.8
2.3
0.86
544
4479
(3019198) Lymphocytes [#/volume] in Blood
372
2695
1.86
13.60
10.9
6.0
e9/l
1.9
1.9
0.01
331
2408
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
289
1965
1.83
12.71
2.4
2.2
nmol/l
70.0
74.7
1.83
254
1795
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
231
1474
1.87
12.40
3.1
2.1
u/l
454.2
252.1
0.69
215
1402
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
366
2694
1.79
12.17
5.3
6.8
umol/l
9.8
11.3
1.39
340
2573
(3018418) pH of Serum or Plasma
214
1341
1.88
12.11
3.7
4.0
ph
7.4
7.4
1.57
32
237
(3013826) Glucose [Moles/volume] in Serum or Plasma
392
2947
1.80
12.11
5.4
4.8
mmol/l
6.8
6.7
0.54
363
2764
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
137
741
2.07
11.87
2.5
1.8
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
114
576
2.18
11.79
8.1
6.4
—
—
—
0
0
(3003396) Base excess in Arterial blood by calculation
109
546
2.19
11.50
5.8
9.1
mmol/l
2.2
1.0
1.92
89
439
(3014576) Chloride [Moles/volume] in Serum or Plasma
117
604
2.14
11.44
5.1
7.3
mmol/l
103.7
104.3
0.60
110
592
(3036481) Cortisol [Moles/volume] in Serum or Plasma
98
476
2.24
11.14
2.0
2.1
nmol/l
380.9
369.8
0.18
91
450
(3018405) Lactate [Moles/volume] in Arterial blood
48
164
3.08
11.11
3.6
4.5
mmol/l
1.4
1.4
0.02
48
159
(3020891) Body temperature
50
176
2.99
11.00
4.1
4.9
—
—
—
0
0
(3002032) Base excess in Venous blood by calculation
88
411
2.31
10.97
4.4
3.4
mmol/l
2.1
2.1
0.02
73
325
(3008152) Bicarbonate [Moles/volume] in Arterial blood
69
290
2.54
10.83
7.4
9.3
mmol/l
25.9
24.4
1.89
64
271
(3023368) Bacteria identified in Blood by Culture
205
1311
1.81
10.64
5.1
4.1
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
101
515
2.13
10.14
2.4
1.7
—
—
—
0
0
(3007853) Bacteria identified in Skin by Aerobe culture
113
604
2.05
10.01
2.0
1.6
—
—
—
0
0
(3029937) Albumin [Presence] in Urine by Test strip
205
1349
1.75
9.48
5.2
3.2
estimate
0.0
0.0
0.69
51
453
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
133
767
1.92
9.45
3.0
3.0
mmol/l
2.4
2.4
0.69
111
674
(3026008) Bacteria identified in Urine by Culture
178
1125
1.79
9.45
3.9
2.5
—
—
—
0
0
(3011397) Hemoglobin [Presence] in Urine by Test strip
176
1112
1.79
9.34
4.4
3.0
—
—
—
0
0
(40761535) Cells panel - Urine sediment
82
398
2.21
9.30
3.3
3.0
—
—
—
0
0
(3019069) Monocytes/100 leukocytes in Blood
329
2467
1.66
9.27
10.4
6.3
%
8.2
8.7
2.44
306
2345
(42870588) Differential panel, method unspecified - Blood
247
1720
1.69
9.25
7.8
6.0
—
—
—
0
0
(3020682) Albumin/Creatinine [Ratio] in Urine
223
1513
1.71
9.19
3.4
4.0
mg/mmol
4.5
9.6
1.43
133
1000
(3020485) Acetaminophen [Moles/volume] in Serum or Plasma
15
24
6.37
9.02
2.5
1.8
umol/l
130.5
58.4
—
7
13
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
97
509
2.06
9.00
2.4
1.6
—
—
—
0
0
(3002173) Hemoglobin [Mass/volume] in Arterial blood
91
467
2.10
8.95
6.2
9.9
g/l
125.6
123.7
0.44
85
454
(3044889) 12 lead EKG panel
456
3747
1.68
8.74
4.3
3.3
—
—
—
0
0
(3031040) Bacteria [#/volume] in Urine by Automated count
398
3169
1.63
8.55
6.0
3.6
e6/l
7929.8
130.3
—
8
47
(3006504) Eosinophils/100 leukocytes in Blood
324
2455
1.62
8.51
9.5
6.0
%
2.4
2.9
4.04
300
2314
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
572
5044
1.92
8.21
7.1
5.1
mmol/mol
40.2
39.4
1.04
529
4774
(3002030) Lymphocytes/100 leukocytes in Blood
332
2545
1.60
8.21
9.8
6.0
%
28.2
28.3
0.08
307
2410
(3018010) Neutrophils/100 leukocytes in Blood
327
2509
1.59
7.98
9.1
5.8
%
57.9
56.7
0.93
302
2385
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
24
710
0.31
7.96
1.4
1.7
—
—
—
0
0
(3000850) Epithelial cells [#/volume] in Urine
151
958
1.74
7.75
2.9
2.3
e6/l
5.1
5.0
0.01
133
856
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
77
395
2.07
7.57
3.3
2.2
ug/l
11.7
8.9
0.17
64
356
(3022096) Basophils/100 leukocytes in Blood
311
2379
1.57
7.55
9.4
6.0
%
0.6
0.7
3.68
292
2250
(3019550) Sodium [Moles/volume] in Serum or Plasma
614
5589
2.20
7.49
21.1
13.6
mmol/l
139.2
139.7
3.96
605
5459
(3012516) Albumin [Mass/volume] in Urine
205
1430
1.63
7.30
2.9
3.3
mg/l
379.1
294.4
0.09
126
954
(3023103) Potassium [Moles/volume] in Serum or Plasma
615
5618
2.17
7.16
20.8
13.6
mmol/l
4.0
4.0
1.33
606
5481
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
17
39
4.45
6.99
1.6
1.6
—
—
—
0
0
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
255
1908
1.54
6.59
4.3
3.2
ng/l
20.9
47.1
2.26
179
1222
(3019060) Gas panel - Arterial blood
59
293
2.11
6.32
4.6
7.1
—
—
—
0
0
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
14
30
4.75
6.23
2.4
2.3
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
27
666
0.38
6.08
1.5
1.4
—
—
—
0
0
(3001122) Ferritin [Mass/volume] in Serum or Plasma
279
2160
1.50
6.00
3.0
2.6
ug/l
134.4
137.4
0.07
255
2025
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
469
4056
1.52
5.72
4.7
3.2
u/l
51.5
50.8
0.06
437
3851
(3004119) Hemoglobin [Mass/volume] in Venous blood
57
292
2.04
5.64
2.3
3.1
g/l
129.0
132.1
0.46
57
287
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
15
470
0.30
5.53
1.5
1.4
—
—
—
0
0
(3004789) Transferrin [Mass/volume] in Serum or Plasma
108
685
1.69
5.44
2.1
2.3
g/l
2.5
2.3
1.13
96
645
(3042517) Benzodiazepines panel - Urine
8
5
16.17
5.42
1.3
1.0
—
—
—
0
0
(3000991) Gas panel - Venous blood
71
401
1.86
5.30
7.0
8.5
—
—
—
0
0
(3003458) Phosphate [Moles/volume] in Serum or Plasma
101
635
1.70
5.25
3.6
6.4
mmol/l
1.0
1.0
0.14
92
600
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
82
1302
0.58
5.16
2.5
2.6
ug/l
0.6
0.7
1.42
58
756
(3022948) Iron [Moles/volume] in Serum or Plasma
112
732
1.64
5.02
2.2
2.3
umol/l
12.6
14.1
1.37
104
687
(3012095) Magnesium [Moles/volume] in Serum or Plasma
122
815
1.61
5.00
2.5
3.6
mmol/l
0.8
0.8
0.95
114
779
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
330
3897
0.70
4.99
3.0
3.1
—
—
—
0
0
(3026782) Osmolality of Urine
133
908
1.58
4.98
3.0
2.5
mosm/kgh2o
508.9
577.8
2.36
112
785
(3037467) Urinalysis macro (dipstick) panel - Urine
411
3509
1.44
4.97
4.8
3.8
—
—
—
0
0
(3030467) Casts [#/volume] in Urine by Automated count
179
1306
1.51
4.96
3.2
2.8
e6/l
0.6
0.4
0.29
145
972
(4010399)
65
366
1.86
4.91
1.5
1.4
—
—
—
0
0
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
228
1750
1.46
4.89
3.6
2.9
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
176
1284
1.50
4.86
9.5
4.6
—
—
—
0
0
(3007628) Bicarbonate [Moles/volume] standard in Venous blood
42
204
2.13
4.80
6.6
3.2
mmol/l
24.3
24.3
0.00
37
186
(44816559) Phosphatidylethanol [Mass/volume] in Blood
31
134
2.38
4.66
1.5
1.4
—
—
—
0
0
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
53
287
1.92
4.52
2.1
3.6
pmol/l
4.5
4.7
0.56
45
254
(3013707) Erythrocyte sedimentation rate by Westergren method
443
3878
1.42
4.37
3.8
3.8
mm/h
10.7
10.0
0.55
404
3628
(36304419) Bacteria [Presence] in Urine
172
1285
1.46
4.15
3.0
2.7
—
—
—
0
0
(3019977) pH of Arterial blood
10
23
4.40
4.10
6.4
4.9
—
7.4
—
0
7
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
51
283
1.87
4.06
2.2
1.4
—
—
—
0
0
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
576
5334
1.57
4.01
6.1
4.1
mmol/l
6.3
5.9
5.22
531
4966
(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood
9
14
6.50
3.99
7.0
2.1
—
—
—
0
0
(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood
9
14
6.50
3.99
7.0
2.1
—
—
—
0
0
(3017181) Myelocytes/100 leukocytes in Blood
70
431
1.70
3.94
7.5
4.2
%
1.0
0.9
0.14
27
133
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
163
1223
1.44
3.81
2.9
3.0
ng/l
1411.4
909.4
0.27
136
1019
(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing
7
8
8.83
3.78
1.1
1.1
—
—
—
0
0
(3021589) Normoblasts [#/volume] in Blood
280
2310
1.36
3.73
13.8
8.7
e9/l
0.0
0.0
0.23
235
1912
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
60
361
1.73
3.68
1.9
1.5
—
—
—
0
0
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
94
635
1.56
3.66
2.2
2.4
%
21.1
24.4
1.32
76
555
(3018095) Leukocytes [#/volume] in Urine
213
1690
1.38
3.59
4.0
3.3
e6/l
65.2
88.5
0.28
165
1206
(1002224) Polysomnography panel
12
327
0.36
3.40
1.1
1.1
—
—
—
0
0
(3003181) Sodium [Moles/volume] in Urine
17
65
2.66
3.32
1.8
1.3
mmol/l
36.8
58.0
—
10
60
(3035350) Ketones [Presence] in Urine by Test strip
301
2545
1.33
3.30
4.6
3.0
estimate
0.0
0.0
0.00
51
461
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
156
1190
1.41
3.29
1.4
1.2
u/ml
0.7
1.6
1.61
40
360
(3010421) pH of Blood
25
116
2.20
3.26
2.6
3.1
ph
7.4
7.4
1.79
19
94
(3022217) INR in Platelet poor plasma by Coagulation assay
81
546
1.55
3.19
14.5
18.8
inr
1.1
1.3
0.50
11
80
(3027945) Reticulocytes/100 erythrocytes in Blood
72
475
1.58
3.12
2.8
2.9
%
1.7
1.8
0.52
66
436
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
72
476
1.57
3.09
3.9
2.7
—
—
—
0
0
(3021440) Promyelocytes/100 leukocytes in Blood
63
404
1.62
3.07
8.0
4.3
%
0.1
0.1
0.36
23
119
(3006653) Thiamine [Moles/volume] in Blood
10
29
3.49
3.05
1.1
1.4
nmol/l
167.0
161.9
—
10
29
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
246
2038
1.33
3.04
5.1
3.1
—
—
—
0
0
(3026389) Candida sp identified in Specimen by Organism specific culture
13
45
2.93
3.04
1.7
1.2
—
—
—
0
0
(3044290) Cell count panel - Cerebral spinal fluid
22
101
2.22
2.96
1.1
1.3
—
—
—
0
0
(1616796) Gas panel - Central venous blood
22
103
2.17
2.83
1.8
2.7
—
—
—
0
0
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
70
470
1.55
2.82
2.4
2.4
g/l
0.2
0.2
0.12
62
438
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
110
810
1.43
2.82
2.3
2.5
e6/l
0.7
0.9
0.71
73
454
(3021601) Nitrite [Presence] in Urine by Test strip
296
2547
1.29
2.69
5.6
4.2
estimate
0.0
0.0
0.00
54
471
(3019473) Protein [Mass/volume] in Cerebral spinal fluid
25
126
2.02
2.69
1.0
1.2
mg/l
650.2
470.5
0.58
25
119
(3042936) Bacteria identified in Isolate by Culture
102
749
1.43
2.66
2.1
2.1
—
—
—
0
0
(3009261) Glucose [Presence] in Urine by Test strip
297
2564
1.28
2.61
4.7
3.1
estimate
0.0
0.0
0.50
51
435
(3026493) Urate [Moles/volume] in Serum or Plasma
109
1428
0.72
2.59
2.0
2.6
umol/l
7247.9
6357.6
0.07
91
1292
(3044242) Glucose [Moles/volume] in Arterial blood
9
25
3.63
2.58
1.9
4.7
—
—
—
0
0
(3002582) Erythrocytes [#/volume] in Urine
178
1437
1.33
2.58
3.6
2.8
e6/l
49.8
66.7
0.19
145
1110
(3012501) Base excess in Blood by calculation
20
94
2.16
2.57
2.7
3.1
mmol/l
2.5
2.4
0.06
15
60
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
49
310
1.63
2.55
4.2
3.0
mmol/l
2.2
1.7
0.64
42
231
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
17
75
2.30
2.53
1.5
1.6
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
121
1552
0.73
2.51
1.3
1.4
—
—
—
0
0
(3035637) Corticotropin [Mass/volume] in Plasma
13
51
2.58
2.45
1.3
1.5
—
—
—
0
0
(3032080) INR in Blood by Coagulation assay
230
1935
1.29
2.44
5.8
7.5
inr
1.1
1.2
0.34
80
565
(3009343) pH of Capillary blood
50
322
1.60
2.43
4.2
3.0
ph
7.4
7.4
—
5
48
(3013512) EKG study
172
1394
1.31
2.41
4.1
3.3
—
—
—
0
0
(3028772) Osteocalcin [Mass/volume] in Serum or Plasma
9
27
3.36
2.40
4.4
3.1
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
24
125
1.95
2.38
2.0
1.7
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
12
46
2.64
2.37
2.8
2.0
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
12
46
2.64
2.37
2.8
2.0
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
12
46
2.64
2.37
2.8
2.0
—
—
—
0
0
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
18
84
2.17
2.36
1.4
1.3
—
—
—
0
0
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
7
17
4.15
2.36
1.3
1.7
—
—
—
0
0
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
50
326
1.58
2.32
2.2
2.9
ng/l
146.8
145.4
0.01
43
286
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
175
1430
1.30
2.30
1.8
1.6
mmol/l
1.6
1.5
1.25
148
1222
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
43
271
1.63
2.29
9.1
12.1
—
—
—
0
0
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
0
59
0.00
2.25
0.0
1.5
—
—
—
0
0
(40767503) Oxygen content in Capillary blood by calculation
19
93
2.07
2.23
2.0
2.4
%
17.5
16.7
—
8
54
(3023520) Reticulocytes [#/volume] in Blood
52
348
1.54
2.17
1.8
3.0
e9/l
66.1
73.3
0.87
46
267
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
14
61
2.32
2.16
1.1
1.3
—
—
—
0
0
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
14
61
2.32
2.16
1.4
1.7
—
—
—
0
0
(3002256) Pathology report gross observation
44
660
0.64
2.14
1.3
1.2
—
—
—
0
0
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
12
49
2.48
2.11
2.7
2.5
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
88
658
1.39
2.09
1.5
1.4
—
—
—
0
0
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
18
89
2.05
2.07
1.5
1.5
—
—
—
0
0
(3030905) Polymorphonuclear cells [#/volume] in Blood
19
96
2.01
2.07
5.6
3.4
e9/l
4.5
4.0
0.53
19
96
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
23
125
1.87
2.05
2.1
1.7
—
—
—
0
0
(3025159) Blasts/100 leukocytes in Blood
55
378
1.50
2.04
8.4
4.4
%
0.0
0.3
1.53
16
100
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
19
98
1.97
1.97
5.7
3.7
%
60.6
55.3
0.96
19
98
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
10
39
2.59
1.93
1.2
1.4
—
—
—
0
0
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
619
5977
1.48
1.92
12.6
9.7
u/l
30.1
29.8
0.12
603
5814
(3017143) Hepatitis C virus Ab [Presence] in Serum
93
714
1.35
1.89
1.6
1.7
—
—
—
0
0
(3032773) Endomysium IgG Ab [Titer] in Serum
12
52
2.33
1.88
1.3
1.1
—
—
—
0
0
(3023511) Choriogonadotropin [Units/volume] in Urine
15
72
2.11
1.87
1.3
1.1
—
—
—
0
0
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
16
79
2.05
1.86
1.1
1.6
—
—
—
0
0
(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma
13
59
2.23
1.85
1.2
1.2
u/l
41.1
46.7
—
7
38
(3014218) Bicarbonate [Moles/volume] standard in Arterial blood
40
263
1.55
1.83
5.9
10.2
mmol/l
25.6
24.4
0.81
35
251
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
210
2422
0.81
1.83
3.8
3.9
—
—
—
0
0
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
40
264
1.55
1.81
1.8
1.5
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
7
23
3.06
1.80
1.0
1.2
—
—
—
0
0
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
13
60
2.19
1.78
1.0
1.3
—
—
—
0
0
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
115
922
1.30
1.74
3.7
3.4
ng/l
257.4
499.7
0.63
83
676
(3022145) Colonoscopy Study observation
43
618
0.67
1.73
1.3
1.4
—
—
—
0
0
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
8
30
2.69
1.73
1.4
2.8
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
21
118
1.80
1.72
1.4
1.4
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
32
203
1.61
1.71
1.2
1.4
—
—
—
0
0
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
17
89
1.93
1.71
1.6
1.6
—
—
—
0
0
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
145
1200
1.27
1.71
1.6
1.8
mg/l
0.9
1.1
0.79
117
918
(40768804) Tissue Pathology biopsy report
170
1993
0.80
1.70
2.1
2.0
—
—
—
0
0
(4035726)
27
427
0.62
1.69
1.5
1.4
—
—
—
0
0
(3002179) Metamyelocytes/100 leukocytes in Blood
55
395
1.43
1.67
7.1
4.0
%
0.6
0.6
0.06
11
93
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
13
62
2.12
1.66
2.7
2.1
—
—
—
0
0
(3023323) Follitropin [Units/volume] in Serum or Plasma
34
221
1.57
1.65
1.5
1.3
iu/l
25.9
27.5
0.09
28
184
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
20
113
1.79
1.62
2.2
1.5
—
—
—
0
0
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
7
26
2.71
1.58
3.6
2.3
—
—
—
0
0
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
7
26
2.71
1.58
3.6
2.3
—
—
—
0
0
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
7
26
2.71
1.58
3.6
2.3
—
—
—
0
0
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
7
26
2.71
1.58
3.6
2.3
—
—
—
0
0
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
65
489
1.36
1.53
2.4
2.7
u/l
25.5
142.2
0.64
55
423
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
0
44
0.00
1.51
0.0
1.2
—
—
—
0
0
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
22
131
1.70
1.51
2.9
2.5
u/l
240.9
1833.1
—
7
50
(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection
6
21
2.87
1.51
4.0
2.5
—
—
—
0
0
(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection
6
21
2.87
1.51
4.0
2.5
—
—
—
0
0
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
47
335
1.43
1.50
3.9
3.7
mmol/l
1.2
1.2
1.04
39
300
(3007164) IgA [Mass/volume] in Serum or Plasma
131
1088
1.25
1.50
1.5
1.4
g/l
2.0
2.4
2.34
79
732
(1761482) Bacteria [#/volume] in Urine by Culture
20
117
1.73
1.46
2.5
4.2
—
—
—
0
0
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
7
151
0.46
1.45
1.7
1.5
—
—
—
0
0
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
6
22
2.74
1.43
1.0
1.1
—
—
—
0
0
(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection
6
22
2.74
1.43
4.0
2.5
—
—
—
0
0
(3024928) Oxygen saturation in Venous blood
18
103
1.77
1.42
2.8
2.9
—
—
—
0
0
(3029080) Hemoglobin [Entitic mass] in Reticulocytes
10
46
2.19
1.40
1.5
2.2
pg
32.4
34.0
—
10
46
(3018677) aPTT in Platelet poor plasma by Coagulation assay
91
729
1.29
1.40
1.7
2.3
s
29.2
29.5
0.21
86
709
(3008898) HLA-B27 [Presence]
14
248
0.56
1.38
1.1
1.1
—
—
—
0
0
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
29
191
1.54
1.37
1.3
2.4
g/l
1.9
1.4
1.33
24
167
(3017732) Neutrophils [#/volume] in Blood
52
386
1.38
1.34
7.9
2.4
e9/l
4.3
4.1
0.15
42
321
(1617658) Protocol used for examination of sentinel lymph nodes
0
39
0.00
1.34
0.0
1.1
—
—
—
0
0
(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma
0
41
0.00
1.31
0.0
1.3
—
7.0
—
0
30
(3016018) Differential panel - Cerebral spinal fluid
9
43
2.11
1.30
1.2
1.2
—
—
—
0
0
(3021901) Oxygen saturation in Capillary blood
16
91
1.78
1.30
1.4
2.3
—
—
—
0
0
(3022192) Triglyceride [Mass/volume] in Serum or Plasma
5
18
2.79
1.28
4.2
2.6
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
102
840
1.25
1.27
1.5
1.6
—
—
—
0
0
(44790047)
13
70
1.87
1.24
1.5
1.6
—
—
—
0
0
(44790048)
13
70
1.87
1.24
1.5
1.6
—
—
—
0
0
(44790049)
13
70
1.87
1.24
1.5
1.6
—
—
—
0
0
(44806118)
13
70
1.87
1.24
1.5
1.6
—
—
—
0
0
(3020961) Endomysium IgA Ab [Titer] in Serum
38
271
1.43
1.24
1.2
1.1
—
104.2
—
0
5
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
570
5499
1.25
1.24
18.7
12.2
mg/l
24.4
23.6
0.21
477
4288
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
11
56
1.98
1.22
3.0
2.2
—
—
—
0
0
(3000492) Spirometry study
48
633
0.74
1.22
1.5
1.4
—
—
—
0
0
(3018980) carBAMazepine [Moles/volume] in Serum or Plasma
5
19
2.64
1.22
2.2
3.2
umol/l
28.2
35.4
—
5
14
(3009542) Hematocrit [Volume Fraction] of Blood
510
5312
0.83
1.21
24.7
12.6
%
39.9
41.1
1.83
293
4191
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
13
72
1.82
1.15
1.3
1.5
—
—
—
0
0
(3052851) Hemolysis interference index of Serum or Plasma
22
142
1.57
1.15
1.8
2.9
—
—
—
0
0
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
8
39
2.06
1.15
1.0
1.2
—
—
—
0
0
(40761995) Spermatozoa Progressive [#/volume] in Semen
0
35
0.00
1.15
0.0
3.1
—
—
—
0
0
(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen
0
35
0.00
1.15
0.0
6.1
—
—
—
0
0
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
12
65
1.86
1.14
1.7
1.6
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
53
407
1.33
1.13
1.1
1.1
—
—
—
0
0
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
14
80
1.77
1.13
2.5
1.9
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
31
217
1.45
1.13
2.2
2.2
—
—
—
0
0
(4034850)
27
184
1.49
1.12
8.4
9.2
—
—
—
0
0
(3050449) Albumin [Mass/time] in Urine collected for unspecified duration
21
137
1.55
1.07
2.2
2.3
ug/min
30.9
152.1
1.89
12
83
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
19
121
1.59
1.06
1.1
1.2
—
—
—
0
0
(3004809) Band form neutrophils/100 leukocytes in Blood
14
82
1.72
1.06
3.6
3.4
%
2.3
1.2
—
8
67
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
54
682
0.77
1.03
1.4
1.5
—
—
—
0
0
(4146454)
9
47
1.93
1.02
2.2
2.3
—
—
—
0
0
(3044640) Blood type and Crossmatch panel - Blood
139
1586
0.84
1.01
2.3
2.3
—
—
—
0
0
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
67
541
1.26
1.01
3.2
4.8
u/l
254.5
245.2
0.19
61
517
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
24
164
1.48
1.00
3.0
2.8
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
17
260
0.64
0.99
2.4
1.9
—
—
—
0
0
(4094501)
9
158
0.56
0.99
1.2
1.1
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
54
426
1.29
0.98
4.9
3.3
—
—
—
0
0
(3036071) Salmonella sp Ab [Titer] in Serum
0
30
0.00
0.97
0.0
1.1
—
—
—
0
0
(3026250) Tacrolimus [Mass/volume] in Blood
0
31
0.00
0.96
0.0
28.0
—
7.4
—
0
25
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
52
410
1.29
0.95
3.7
2.5
ml/min/173m2
73.0
71.8
0.06
21
169
(3025468) Yersinia sp identified in Specimen by Organism specific culture
12
70
1.73
0.93
1.3
1.5
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
12
70
1.73
0.93
1.3
1.5
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
27
193
1.42
0.91
2.9
1.9
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
12
71
1.70
0.89
1.3
1.5
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
132
1493
0.86
0.86
4.3
2.7
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
12
72
1.68
0.85
1.3
1.5
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
15
96
1.58
0.85
1.7
1.2
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
15
96
1.58
0.85
1.7
1.2
—
—
—
0
0
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
89
762
1.19
0.80
2.6
2.7
e6/l
3.2
1.9
0.58
52
407
(3030366) Cystatin C [Mass/volume] in Serum or Plasma
9
147
0.61
0.80
2.7
2.9
mg/l
1.7
1.4
—
9
137
(3005570) Glucose [Moles/volume] in Urine
8
48
1.67
0.79
1.5
1.9
—
—
—
0
0
(3019225) pH of Specimen
54
440
1.25
0.79
4.1
4.5
—
—
—
0
0
(3047007) Chlamydophila sp Ab [Presence] in Serum
5
97
0.51
0.78
1.0
1.1
—
—
—
0
0
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
5
98
0.51
0.78
1.0
1.1
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
30
226
1.34
0.77
2.3
3.2
—
—
—
0
0
(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay
5
24
2.09
0.74
1.4
1.4
—
20.8
—
0
6
(3002385) Erythrocyte distribution width [Ratio]
485
4679
1.13
0.74
28.4
14.7
%
13.9
13.5
4.94
473
4588
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
9
55
1.64
0.73
1.6
1.4
—
—
—
0
0
(3045424) Erythrocytes [Presence] in Urine
15
101
1.50
0.70
1.3
1.3
—
—
—
0
0
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
9
58
1.56
0.70
1.4
1.5
nmol/l
—
—
—
0
0
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
5
28
1.79
0.66
1.2
1.3
—
—
—
0
0
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
11
70
1.58
0.65
1.4
1.5
—
—
—
0
0
(21494890) Protein electrophoresis panel - 24 hour Urine
7
44
1.60
0.65
1.1
2.8
—
—
—
0
0
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
75
862
0.85
0.62
1.2
1.2
u/ml
2.4
12.9
3.80
34
373
(3022621) pH of Urine by Test strip
37
298
1.26
0.62
3.6
2.2
—
—
—
0
0
(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma
5
30
1.67
0.61
6.2
3.5
u/ml
686.8
756.7
—
5
30
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
540
5268
1.13
0.60
14.8
10.8
ml/min/173m2
87.9
86.6
0.73
414
4361
(3035285) Chloride [Moles/volume] in Venous blood
10
64
1.57
0.59
1.9
2.6
mmol/l
102.5
105.4
—
10
64
(3033705) Calcium.ionized [Moles/volume] in Venous blood
10
64
1.57
0.59
1.9
2.6
—
—
—
0
0
(3041354) Potassium [Moles/volume] in Venous blood
10
64
1.57
0.59
1.9
2.6
mmol/l
4.2
4.1
—
10
64
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
24
184
1.32
0.58
2.1
1.7
—
—
—
0
0
(3023410) Appearance of Cerebral spinal fluid
8
53
1.52
0.58
1.5
1.3
—
—
—
0
0
(3016650) Hepatitis A virus Ab [Presence] in Serum
15
106
1.42
0.58
1.1
1.1
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
28
220
1.28
0.58
1.4
1.5
—
—
—
0
0
(44813793)
6
35
1.72
0.58
1.2
1.0
—
—
—
0
0
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
6
35
1.72
0.58
1.0
1.1
—
—
—
0
0
(3017817) Protein [Mass] in Urine collected for unspecified duration
6
38
1.58
0.54
1.0
3.0
—
—
—
0
0
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
581
5703
1.14
0.54
5.5
4.5
mmol/l
2.7
2.9
3.87
536
5365
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
110
1215
0.89
0.53
2.4
2.3
—
—
—
0
0
(3048689) Calprotectin [Mass/mass] in Stool
79
697
1.15
0.53
1.8
2.5
ug/g
85.1
137.4
2.18
57
574
(3022313) Gas panel - Capillary blood
29
232
1.26
0.53
3.1
3.2
—
—
—
0
0
(4024509)
6
39
1.54
0.53
1.7
1.3
—
—
—
0
0
(3023419) Bacteria identified in Sputum by Culture
10
66
1.52
0.52
1.7
2.7
—
—
—
0
0
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
6
98
0.61
0.52
1.0
1.1
—
—
—
0
0
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
17
126
1.36
0.52
2.1
1.2
—
—
—
0
0
(3024474) Albumin [Mass/volume] in Cerebral spinal fluid
7
46
1.53
0.48
1.0
1.1
mg/l
222.3
261.5
—
7
38
(3007368) IgG [Mass/volume] in Cerebral spinal fluid
7
48
1.46
0.47
1.0
1.1
mg/l
27.4
35.3
—
7
37
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
10
142
0.70
0.46
3.1
3.1
u/ml
0.3
0.3
—
5
77
(40768800) Prostate Pathology biopsy report
8
118
0.67
0.46
1.0
1.2
—
—
—
0
0
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
55
627
0.87
0.44
4.4
4.0
%
27.1
30.8
2.37
39
448
(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
9
130
0.69
0.43
1.7
6.5
—
317.3
—
0
23
(3025941) Bacteria identified in Stool by Culture
37
313
1.19
0.43
1.5
1.2
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
33
276
1.21
0.43
1.1
1.0
—
—
—
0
0
(3000475) Leukocytes [#/volume] in Synovial fluid
16
122
1.32
0.42
1.4
1.6
e6/l
2146.4
14410.0
1.93
11
91
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
69
615
1.14
0.42
1.6
1.6
—
—
—
0
0
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
40
466
0.85
0.42
2.7
4.9
ug/l
19.7
28.6
0.19
33
377
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
17
131
1.31
0.42
2.4
1.6
—
—
—
0
0
(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum
33
391
0.84
0.42
2.2
2.3
—
16.8
—
0
23
(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay
5
32
1.57
0.42
1.0
2.5
%
100.8
96.8
—
5
32
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
20
158
1.27
0.42
1.2
1.1
—
—
—
0
0
(3033658) Prothrombin time (PT) actual/Normal
141
1310
1.10
0.42
4.6
3.8
%
92.8
92.8
0.01
134
1286
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
5
33
1.52
0.41
1.6
2.2
—
—
—
0
0
(3038071) Oxygen [Partial pressure] in Mixed venous blood
0
15
0.00
0.41
0.0
7.9
—
—
—
0
0
(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection
0
15
0.00
0.41
0.0
1.3
—
—
—
0
0
(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot
0
16
0.00
0.41
0.0
1.0
—
—
—
0
0
(3013637) Mi-2 Ab [Presence] in Serum
0
16
0.00
0.41
0.0
1.0
—
—
—
0
0
(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum
0
16
0.00
0.41
0.0
1.1
—
—
—
0
0
(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood
0
16
0.00
0.41
0.0
7.6
—
—
—
0
0
(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot
0
16
0.00
0.41
0.0
1.0
—
—
—
0
0
(42529582) MDA5 Ab [Presence] in Serum by Line blot
0
16
0.00
0.41
0.0
1.0
—
—
—
0
0
(3044941) Cell count panel - Synovial fluid
11
79
1.40
0.41
1.4
1.4
—
—
—
0
0
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
10
138
0.72
0.41
1.1
1.4
—
—
—
0
0
(1175556) inFLIXimab Ab [Units/volume] in Serum by Immunoassay
0
17
0.00
0.40
0.0
3.4
—
33.1
—
0
6
(3038769) Chlamydophila pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay
0
17
0.00
0.40
0.0
1.0
—
26.8
—
0
17
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
8
60
1.34
0.40
1.3
1.5
—
—
—
0
0
(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay
0
18
0.00
0.40
0.0
1.1
—
—
—
0
0
(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence
0
18
0.00
0.40
0.0
1.0
—
—
—
0
0
(3000093) Morphology [Interpretation] in Blood Narrative
5
35
1.43
0.39
1.4
1.2
—
—
—
0
0
(3051593) INR in Capillary blood by Coagulation assay
0
19
0.00
0.39
0.0
7.7
—
—
—
0
0
(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method
13
170
0.76
0.38
1.8
2.5
%
98.5
90.4
0.44
13
159
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
67
601
1.13
0.38
1.8
1.9
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
15
192
0.78
0.38
1.0
1.2
—
—
—
0
0
(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid
9
67
1.35
0.38
1.0
1.1
—
—
—
0
0
(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum
11
147
0.74
0.37
1.0
1.2
—
2.1
—
0
6
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
13
169
0.76
0.37
1.2
1.2
—
—
—
0
0
(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum
8
115
0.69
0.37
1.0
1.2
—
33.4
—
0
9
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
571
5626
1.10
0.37
5.0
4.2
mmol/l
4.6
4.8
4.75
532
5323
(3006922) Hepatitis E virus Ab [Presence] in Serum
5
37
1.35
0.37
1.0
1.1
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
74
670
1.12
0.37
1.9
2.0
—
—
—
0
0
(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid
9
70
1.29
0.36
1.0
1.1
—
—
—
0
0
(3017446) Testosterone [Moles/volume] in Serum or Plasma
55
615
0.88
0.35
3.0
2.2
nmol/l
12.6
14.3
0.58
47
564
(3006442) Creatine [Moles/volume] in Serum or Plasma
6
43
1.40
0.35
2.8
1.5
—
70.2
—
0
5
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
113
1050
1.09
0.35
1.7
1.5
—
—
—
0
0
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
14
178
0.78
0.34
2.9
1.9
—
—
—
0
0
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
6
44
1.37
0.34
1.0
1.0
—
—
—
0
0
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
19
154
1.24
0.34
1.6
1.4
—
—
—
0
0
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
6
45
1.34
0.34
2.7
3.7
—
—
—
0
0
(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method
21
252
0.83
0.32
2.3
1.8
mg/l
1.6
3.3
1.68
13
180
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
69
628
1.11
0.32
2.4
2.8
umol/l
8.0
8.6
0.06
55
558
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
165
1739
0.93
0.32
3.2
3.5
%
24.0
21.1
1.02
67
719
(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum
31
357
0.86
0.31
1.1
1.2
—
41.3
—
0
16
(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum
7
100
0.70
0.30
1.0
1.1
—
12.3
—
0
8
(40768797) Stomach Pathology biopsy report
76
698
1.10
0.30
1.2
1.2
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
19
157
1.22
0.29
1.2
1.1
—
—
—
0
0
(40768793) Breast Pathology biopsy report
8
107
0.74
0.29
1.3
1.3
—
—
—
0
0
(3000570) Elastase.pancreatic [Mass/mass] in Stool
18
149
1.21
0.28
1.3
1.5
ug/g
224.1
291.1
0.73
11
84
(46235355) HIV 1 and 2 tests - Meaningful Use set
113
1063
1.08
0.27
1.8
1.8
—
—
—
0
0
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
8
65
1.23
0.27
1.1
1.1
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
19
159
1.20
0.27
1.2
1.1
—
—
—
0
0
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
14
171
0.81
0.26
2.6
2.1
—
—
—
0
0
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
10
127
0.78
0.25
1.0
1.2
—
—
—
0
0
(40761511) CBC panel - Blood by Automated count
592
5863
1.08
0.25
19.1
11.4
—
—
—
0
0
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
12
96
1.25
0.24
2.3
1.5
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
22
189
1.17
0.24
1.9
1.7
—
—
—
0
0
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
6
81
0.74
0.24
1.2
1.0
—
—
—
0
0
(3009445) Proteinase 3 Ab [Units/volume] in Serum
26
227
1.15
0.24
1.2
1.4
—
6.7
—
0
11
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
5
38
1.32
0.23
1.2
1.7
—
—
—
0
0
(3021788) Differential panel - Synovial fluid
11
88
1.25
0.22
1.3
1.5
—
—
—
0
0
(4027681)
5
40
1.25
0.22
1.0
1.3
—
—
—
0
0
(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation
18
210
0.85
0.22
1.8
1.9
pmol/l
228.7
233.0
0.04
18
199
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
10
124
0.80
0.21
1.3
1.4
—
—
—
0
0
(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
0
11
0.00
0.21
0.0
4.8
—
—
—
0
0
(3005411) Squamous cell carcinoma Ag [Mass/volume] in Serum or Plasma
0
10
0.00
0.21
0.0
2.3
—
2.8
—
0
5
(3051101) Glucose [Moles/volume] in Cord blood
0
10
0.00
0.21
0.0
5.0
—
—
—
0
0
(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(3010254) Herpes simplex virus identified in Specimen by Organism specific culture
0
12
0.00
0.21
0.0
1.0
—
—
—
0
0
(3038177) Helicobacter pylori Ab [Presence] in Serum
11
89
1.24
0.21
1.7
1.2
—
—
—
0
0
(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum
0
13
0.00
0.21
0.0
1.1
—
—
—
0
0
(40758292) HTLV I+II Ab panel - Serum
0
13
0.00
0.21
0.0
1.4
—
—
—
0
0
(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative
0
13
0.00
0.21
0.0
1.5
—
—
—
0
0
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
86
911
0.94
0.20
1.3
1.3
iu/ml
12.7
32.4
3.96
24
308
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
6
48
1.25
0.20
1.2
1.0
—
—
—
0
0
(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture
0
14
0.00
0.20
0.0
2.0
—
—
—
0
0
(3021162) Amylase [Enzymatic activity/volume] in Specimen
0
14
0.00
0.20
0.0
3.6
—
4409.8
—
0
14
(3001684) Respiratory syncytial virus Ag [Presence] in Specimen
0
14
0.00
0.20
0.0
1.0
—
—
—
0
0
(3010813) Leukocytes [#/volume] in Blood
627
6305
0.91
0.19
36.9
17.6
e9/l
7.2
6.6
9.65
616
6156
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
6
51
1.18
0.19
1.0
1.6
—
—
—
0
0
(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight
6
53
1.13
0.18
1.2
1.3
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
26
290
0.89
0.18
1.3
1.3
—
—
—
0
0
(3000963) Hemoglobin [Mass/volume] in Blood
627
6303
0.92
0.18
36.8
17.7
g/l
137.2
139.9
4.50
619
6228
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
5
67
0.74
0.17
1.0
1.1
—
—
—
0
0
(3026361) Erythrocytes [#/volume] in Blood
627
6301
0.92
0.16
36.6
17.6
e12/l
4.6
4.6
1.76
615
6151
(3011985) Renin [Units/volume] in Plasma
8
70
1.14
0.16
1.3
1.2
mu/l
40.2
56.0
—
8
63
(3035941) MCH [Entitic mass]
627
6300
0.92
0.15
36.2
17.5
pg
30.1
30.4
2.69
619
6226
(3019832) Treponema pallidum Ab [Presence] in Serum
44
472
0.93
0.15
1.5
1.7
—
—
—
0
0
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
9
78
1.16
0.15
1.1
1.1
—
—
—
0
0
(3049717) Cytology report of Urine Cyto stain
16
182
0.88
0.15
1.6
2.5
—
—
—
0
0
(3024731) MCV [Entitic volume]
627
6299
0.93
0.15
36.4
17.5
fl
90.4
90.6
0.49
619
6225
(3005719) IgG [Mass/volume] in Serum or Plasma
46
430
1.07
0.15
3.1
2.4
g/l
10.8
10.6
0.14
40
395
(3013139) Helicobacter pylori Ag [Presence] in Stool
36
333
1.09
0.14
1.2
1.2
—
—
—
0
0
(3037121) Protein [Mass/volume] in Urine
16
181
0.88
0.14
1.6
4.1
g/l
0.1
0.2
—
8
87
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
8
96
0.83
0.14
1.6
3.3
—
—
—
0
0
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
8
96
0.83
0.14
1.1
1.1
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
50
474
1.06
0.11
1.4
1.5
—
—
—
0
0
(40768443) Skin Pathology biopsy report
20
182
1.10
0.11
1.4
1.2
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
16
177
0.90
0.10
1.3
1.1
—
—
—
0
0
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
11
96
1.15
0.10
1.2
1.4
—
—
—
0
0
(3007461) Platelets [#/volume] in Blood
627
6292
0.94
0.10
36.3
17.6
e9/l
255.3
249.4
1.36
616
6154
(3037522) Nuclear Ab [Titer] in Serum
72
747
0.96
0.10
1.4
1.3
titre
382.9
437.3
—
7
149
(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma
26
279
0.93
0.10
2.1
1.7
nmol/l
41.2
38.5
0.16
26
271
(40768795) Lymph node Pathology biopsy report
5
46
1.09
0.09
1.0
1.2
—
—
—
0
0
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
5
47
1.06
0.09
1.4
1.1
—
—
—
0
0
(3004588) Protein electrophoresis panel - Serum or Plasma
30
282
1.07
0.09
2.0
2.4
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
19
175
1.09
0.08
1.3
1.7
—
—
—
0
0
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
7
64
1.09
0.08
1.0
1.1
—
—
—
0
0
(3008757) Leukocyte morphology finding [Identifier] in Blood
7
65
1.08
0.08
8.6
4.2
—
—
—
0
0
(3014051) Protein [Presence] in Urine by Test strip
11
98
1.12
0.07
1.5
1.8
—
—
—
0
0
(3014148) Varicella zoster virus Ab [Titer] in Serum
6
72
0.83
0.07
1.3
1.2
—
—
—
0
0
(3003338) MCHC [Mass/volume]
493
4959
0.98
0.07
34.8
15.1
g/l
332.4
334.4
5.02
488
4927
(3042111) Morphology [Interpretation] in Bone marrow Narrative
7
82
0.85
0.07
1.1
1.9
—
—
—
0
0
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
215
2176
0.98
0.06
3.2
3.9
ug/l
2.7
1.9
0.31
192
1997
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
545
5429
1.02
0.05
4.4
3.8
mmol/l
1.6
1.4
6.03
501
5114
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
10
110
0.91
0.05
1.1
2.0
—
—
—
0
0
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
13
120
1.08
0.05
1.3
1.2
—
—
—
0
0
(3000620) Complement C3 [Mass/volume] in Serum or Plasma
15
159
0.94
0.03
2.3
1.4
g/l
1.2
1.2
0.08
15
151
(4306422)
10
92
1.09
0.03
1.2
1.2
—
—
—
0
0
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
18
189
0.95
0.03
1.1
1.4
miu/ml
131.8
224.1
—
6
87
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
35
359
0.97
0.02
1.1
1.2
iu/ml
128.2
144.5
0.10
16
149
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
26
252
1.03
0.02
1.7
2.0
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
32
313
1.02
0.01
1.8
2.0
—
—
—
0
0
(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay
10
94
1.06
0.01
2.7
4.4
u/ml
173.5
360.0
—
10
87
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
562
5613
1.01
0.01
4.9
4.1
mmol/l
1.3
1.4
8.94
522
5294
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
16
165
0.97
0.00
1.1
1.1
—
—
—
0
0
(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence
18
185
0.97
0.00
1.6
1.6
—
277.1
—
0
7
(40760888) Immunoglobulin light chains.free panel - Serum
10
102
0.98
0.00
3.1
3.5
—
—
—
0
0
(3017766) Complement C4 [Mass/volume] in Serum or Plasma
15
152
0.99
0.00
2.4
1.4
g/l
0.2
0.2
0.20
15
145
(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay
8
87
0.92
0.00
1.1
1.1
%
127.5
117.0
—
8
81
(40766799) MGMT gene methylation score in Tissue by Molecular genetics method
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(40760435) Tropomyosin IgE Ab [Units/volume] in Serum
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood
0
6
0.00
0.00
0.0
1.7
—
—
—
0
0
(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3017115) Methotrexate [Moles/volume] in Serum or Plasma
0
9
0.00
0.00
0.0
5.3
—
0.2
—
0
9
(3000285) Sodium [Moles/volume] in Blood
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3011436) Histone Ab [Units/volume] in Serum
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
7
70
1.00
0.00
1.4
1.5
—
—
—
0
0
(3023436) Glucagon [Mass/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
2.4
—
190.4
—
0
5
(3032868) Hemoglobin electrophoresis panel in Blood
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
(3037756) Immunofixation for Serum or Plasma
9
92
0.98
0.00
1.6
1.6
—
—
—
0
0
(3043870) Heparin induced platelet Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma
5
53
0.94
0.00
3.2
4.1
—
58.4
—
0
18
(3045142) Bone marrow Pathology biopsy report
5
57
0.88
0.00
1.2
1.3
—
—
—
0
0
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
5
50
1.00
0.00
1.2
1.2
—
—
—
0
0
(3047166) Epithelial cells [#/area] in Urine sediment by Automated count
0
8
0.00
0.00
0.0
3.5
—
0.4
—
0
8
(3025886) Oxalate [Mass/time] in 24 hour Urine
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3009876) Amylase isoenzyme 3 panel - Serum or Plasma
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3040668) CNBP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
5
52
0.96
0.00
1.0
1.7
—
—
—
0
0
(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid
0
7
0.00
0.00
0.0
1.4
—
—
—
0
0
(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(21494567) Legionella sp IgM Ab [Presence] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3026726) Creatinine [Moles/volume] in Specimen
0
9
0.00
0.00
0.0
3.8
—
188.3
—
0
9
(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3027653) Mycophenolate [Mass/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
2.3
—
2.9
—
0
6
(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(4062490)
5
52
0.96
0.00
2.6
1.3
—
—
—
0
0
(3013293) Extractable nuclear Ab [Presence] in Serum
0
5
0.00
0.00
0.0
1.8
—
—
—
0
0
(3032743) Legionella sp IgG Ab [Presence] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
0
7
0.00
0.00
0.0
1.4
—
—
—
0
0
(3028717) Thiamine [Mass/volume] in Blood
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3005011) Chlamydia sp Ab [Titer] in Serum
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection
0
8
0.00
0.00
0.0
1.4
—
—
—
0
0
(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
9
92
0.98
0.00
1.0
1.1
—
—
—
0
0
(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method
0
5
0.00
0.00
0.0
2.2
—
—
—
0
0
(3037441) Creatinine [Moles/volume] in Peritoneal dialysis fluid
0
5
0.00
0.00
0.0
5.0
—
416.8
—
0
5
(3042631) Mycobacterium sp identified in Specimen
6
62
0.97
0.00
1.5
2.7
—
—
—
0
0
(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3027570) Oxalate [Moles/time] in 24 hour Urine
0
5
0.00
0.00
0.0
1.4
—
343.8
—
0
5
(3023383) Lactate [Moles/volume] in Pleural fluid
0
6
0.00
0.00
0.0
1.2
—
5.9
—
0
6
(3035457) Cefaclor IgE Ab [Units/volume] in Serum
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3028026) IgM [Mass/volume] in Serum or Plasma
35
350
1.00
0.00
1.9
1.7
g/l
1.0
1.4
1.49
29
326
(3034552) Adenosine deaminase [Enzymatic activity/volume] in Cerebral spinal fluid
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection
0
5
0.00
0.00
0.0
6.6
—
—
—
0
0
(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(4268621)
6
59
1.02
0.00
2.2
2.4
—
—
—
0
0
(3032057) Clostridioides difficile [Presence] in Stool
0
8
0.00
0.00
0.0
2.0
—
—
—
0
0
(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3001556) Androgen free Index in Serum or Plasma
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
5
50
1.00
0.00
1.4
1.8
—
—
—
0
0
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
5
50
1.00
0.00
1.2
1.2
—
—
—
0
0
(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid
0
6
0.00
0.00
0.0
1.7
—
—
—
0
0
(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum
9
97
0.93
0.00
1.1
1.1
—
110.4
—
0
20
(3029396) Erythrocyte agglutination [Presence] in Blood
0
6
0.00
0.00
0.0
2.3
—
—
—
0
0
(3050794) Legionella sp Ab [Presence] in Serum
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3005685) Amylase.salivary [Enzymatic activity/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.0
—
65.7
—
0
6

Mortality – FinRegistry

↥

Association

Association between endpoint F5_SCHIZPER and mortality.

Females

Parameter HR [95% CI] p-value
F5_SCHIZPER 3.098 [2.45, 3.92] < 0.001
Birth year 0.994 [0.99, 1.0] 0.156

During the follow-up period (1.1.1998 — 31.12.2019), 111 out of 1025 females with F5_SCHIZPER died.

Males

Parameter HR [95% CI] p-value
F5_SCHIZPER 2.607 [2.21, 3.07] < 0.001
Birth year 0.988 [0.98, 1.0] 0.01

During the follow-up period (1.1.1998 — 31.12.2019), 248 out of 1867 males with F5_SCHIZPER died.

Mortality risk

Mortality risk for people of age

years, who have F5_SCHIZPER.

N-year risk Females Males
1 0.197% 0.405%
5 1.649% 2.752%
10 4.044% 7.078%
15 7.98% 13.515%
20 14.365% 22.207%

Relationships between endpoints

↥

Index endpoint: F5_SCHIZPER – Schizoid personality disorder

GWS hits: -

Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
Extremity
rg [CI]
Extremity
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
loading spinner Loading data